id	sid	tid	token	lemma	pos
ajst-1502	1	1	academic	academic	ADJ
ajst-1502	1	2	journal	journal	NOUN
ajst-1502	1	3	of	of	ADP
ajst-1502	1	4	science	science	NOUN
ajst-1502	1	5	and	and	CCONJ
ajst-1502	1	6	technology	technology	NOUN
ajst-1502	1	7	issn	issn	NOUN
ajst-1502	1	8	:	:	PUNCT
ajst-1502	1	9	2771	2771	NUM
ajst-1502	1	10	-	-	SYM
ajst-1502	1	11	3032	3032	NUM
ajst-1502	1	12	|	|	NOUN
ajst-1502	1	13	vol	vol	NOUN
ajst-1502	1	14	.	.	PROPN
ajst-1502	2	1	2	2	NUM
ajst-1502	2	2	,	,	PUNCT
ajst-1502	2	3	no	no	INTJ
ajst-1502	2	4	.	.	NOUN
ajst-1502	2	5	3	3	NUM
ajst-1502	2	6	,	,	PUNCT
ajst-1502	2	7	2022	2022	NUM
ajst-1502	2	8	84	84	NUM
ajst-1502	2	9	analysis	analysis	NOUN
ajst-1502	2	10	of	of	ADP
ajst-1502	2	11	the	the	DET
ajst-1502	2	12	relationship	relationship	NOUN
ajst-1502	2	13	between	between	ADP
ajst-1502	2	14	il‐10	il‐10	NOUN
ajst-1502	2	15	gene	gene	NOUN
ajst-1502	2	16	polymorphism	polymorphism	NOUN
ajst-1502	2	17	and	and	CCONJ
ajst-1502	2	18	hypertension	hypertension	NOUN
ajst-1502	2	19	susceptibility	susceptibility	NOUN
ajst-1502	2	20	in	in	ADP
ajst-1502	2	21	han	han	PROPN
ajst-1502	2	22	nationality	nationality	NOUN
ajst-1502	2	23	in	in	ADP
ajst-1502	2	24	jianghan	jianghan	PROPN
ajst-1502	2	25	plain	plain	PROPN
ajst-1502	2	26	feng	feng	PROPN
ajst-1502	2	27	cao	cao	PROPN
ajst-1502	2	28	,	,	PUNCT
ajst-1502	2	29	yinchun	yinchun	PROPN
ajst-1502	2	30	yang	yang	PROPN
ajst-1502	2	31	,	,	PUNCT
ajst-1502	2	32	wenli	wenli	PROPN
ajst-1502	2	33	xu	xu	PROPN
ajst-1502	2	34	,	,	PUNCT
ajst-1502	2	35	siqi	siqi	PROPN
ajst-1502	2	36	liu	liu	PROPN
ajst-1502	2	37	,	,	PUNCT
ajst-1502	2	38	xu	xu	PROPN
ajst-1502	2	39	wu	wu	PROPN
ajst-1502	2	40	,	,	PUNCT
ajst-1502	2	41	xianglin	xianglin	PROPN
ajst-1502	2	42	cheng	cheng	PROPN
ajst-1502	2	43	*	*	PUNCT
ajst-1502	2	44	the	the	DET
ajst-1502	2	45	first	first	ADJ
ajst-1502	2	46	clinical	clinical	ADJ
ajst-1502	2	47	medical	medical	ADJ
ajst-1502	2	48	college	college	PROPN
ajst-1502	2	49	of	of	ADP
ajst-1502	2	50	yangtze	yangtze	PROPN
ajst-1502	2	51	university	university	PROPN
ajst-1502	2	52	(	(	PUNCT
ajst-1502	2	53	the	the	DET
ajst-1502	2	54	first	first	ADJ
ajst-1502	2	55	affiliated	affiliated	ADJ
ajst-1502	2	56	hospital	hospital	NOUN
ajst-1502	2	57	of	of	ADP
ajst-1502	2	58	yangtze	yangtze	PROPN
ajst-1502	2	59	university	university	PROPN
ajst-1502	2	60	)	)	PUNCT
ajst-1502	2	61	,	,	PUNCT
ajst-1502	2	62	hebei	hebei	PROPN
ajst-1502	2	63	,	,	PUNCT
ajst-1502	2	64	china	china	PROPN
ajst-1502	2	65	*	*	PUNCT
ajst-1502	2	66	corresponding	correspond	VERB
ajst-1502	2	67	author	author	NOUN
ajst-1502	2	68	:	:	PUNCT
ajst-1502	2	69	xianglin	xianglin	PROPN
ajst-1502	2	70	cheng	cheng	PROPN
ajst-1502	2	71	,	,	PUNCT
ajst-1502	2	72	(	(	PUNCT
ajst-1502	2	73	email	email	NOUN
ajst-1502	2	74	:	:	PUNCT
ajst-1502	2	75	45423626@qq.com	45423626@qq.com	NUM
ajst-1502	2	76	)	)	PUNCT
ajst-1502	2	77	abstract	abstract	NOUN
ajst-1502	2	78	:	:	PUNCT
ajst-1502	2	79	objective	objective	NOUN
ajst-1502	2	80	:	:	PUNCT
ajst-1502	2	81	to	to	PART
ajst-1502	2	82	analyze	analyze	VERB
ajst-1502	2	83	the	the	DET
ajst-1502	2	84	association	association	NOUN
ajst-1502	2	85	between	between	ADP
ajst-1502	2	86	interleukin-10	interleukin-10	PROPN
ajst-1502	2	87	(	(	PUNCT
ajst-1502	2	88	il-10	il-10	PRON
ajst-1502	2	89	)	)	PUNCT
ajst-1502	2	90	promoter-1082	promoter-1082	NOUN
ajst-1502	2	91	and	and	CCONJ
ajst-1502	2	92	-819	-819	PROPN
ajst-1502	2	93	polymorphisms	polymorphism	NOUN
ajst-1502	2	94	and	and	CCONJ
ajst-1502	2	95	hypertension	hypertension	NOUN
ajst-1502	2	96	in	in	ADP
ajst-1502	2	97	han	han	PROPN
ajst-1502	2	98	nationality	nationality	NOUN
ajst-1502	2	99	in	in	ADP
ajst-1502	2	100	jianghan	jianghan	PROPN
ajst-1502	2	101	plain	plain	PROPN
ajst-1502	2	102	.	.	PUNCT
ajst-1502	3	1	methods	method	NOUN
ajst-1502	3	2	:	:	PUNCT
ajst-1502	3	3	a	a	DET
ajst-1502	3	4	total	total	NOUN
ajst-1502	3	5	of	of	ADP
ajst-1502	3	6	50	50	NUM
ajst-1502	3	7	han	han	NOUN
ajst-1502	3	8	patients	patient	NOUN
ajst-1502	3	9	with	with	ADP
ajst-1502	3	10	hypertension	hypertension	NOUN
ajst-1502	3	11	in	in	ADP
ajst-1502	3	12	jianghan	jianghan	PROPN
ajst-1502	3	13	plain	plain	PROPN
ajst-1502	3	14	,	,	PUNCT
ajst-1502	3	15	who	who	PRON
ajst-1502	3	16	were	be	AUX
ajst-1502	3	17	hospitalized	hospitalize	VERB
ajst-1502	3	18	in	in	ADP
ajst-1502	3	19	our	our	PRON
ajst-1502	3	20	hospital	hospital	NOUN
ajst-1502	3	21	from	from	ADP
ajst-1502	3	22	march	march	PROPN
ajst-1502	3	23	2018	2018	NUM
ajst-1502	3	24	to	to	ADP
ajst-1502	3	25	april	april	PROPN
ajst-1502	3	26	2018	2018	NUM
ajst-1502	3	27	,	,	PUNCT
ajst-1502	3	28	were	be	AUX
ajst-1502	3	29	selected	select	VERB
ajst-1502	3	30	as	as	ADP
ajst-1502	3	31	the	the	DET
ajst-1502	3	32	experimental	experimental	ADJ
ajst-1502	3	33	group	group	NOUN
ajst-1502	3	34	.	.	PUNCT
ajst-1502	4	1	50	50	NUM
ajst-1502	4	2	healthy	healthy	ADJ
ajst-1502	4	3	han	han	PROPN
ajst-1502	4	4	chinese	chinese	PROPN
ajst-1502	4	5	people	people	NOUN
ajst-1502	4	6	in	in	ADP
ajst-1502	4	7	jianghan	jianghan	PROPN
ajst-1502	4	8	plain	plain	PROPN
ajst-1502	4	9	were	be	AUX
ajst-1502	4	10	selected	select	VERB
ajst-1502	4	11	as	as	ADP
ajst-1502	4	12	the	the	DET
ajst-1502	4	13	control	control	NOUN
ajst-1502	4	14	group	group	NOUN
ajst-1502	4	15	.	.	PUNCT
ajst-1502	5	1	after	after	ADP
ajst-1502	5	2	a	a	DET
ajst-1502	5	3	series	series	NOUN
ajst-1502	5	4	of	of	ADP
ajst-1502	5	5	reactions	reaction	NOUN
ajst-1502	5	6	such	such	ADJ
ajst-1502	5	7	as	as	ADP
ajst-1502	5	8	genomic	genomic	ADJ
ajst-1502	5	9	dna	dna	NOUN
ajst-1502	5	10	extraction	extraction	NOUN
ajst-1502	5	11	and	and	CCONJ
ajst-1502	5	12	pcr	pcr	ADJ
ajst-1502	5	13	amplification	amplification	NOUN
ajst-1502	5	14	,	,	PUNCT
ajst-1502	5	15	polymorphisms	polymorphism	NOUN
ajst-1502	5	16	of	of	ADP
ajst-1502	5	17	il-10	il-10	NOUN
ajst-1502	5	18	-	-	PUNCT
ajst-1502	5	19	819	819	NUM
ajst-1502	5	20	and	and	CCONJ
ajst-1502	5	21	-1082	-1082	PROPN
ajst-1502	5	22	were	be	AUX
ajst-1502	5	23	performed	perform	VERB
ajst-1502	5	24	using	use	VERB
ajst-1502	5	25	abi	abi	PROPN
ajst-1502	5	26	's	's	PART
ajst-1502	5	27	bat3.1	bat3.1	PROPN
ajst-1502	5	28	sequencing	sequencing	NOUN
ajst-1502	5	29	kit	kit	NOUN
ajst-1502	5	30	.	.	PUNCT
ajst-1502	6	1	analysis	analysis	NOUN
ajst-1502	6	2	and	and	CCONJ
ajst-1502	6	3	analysis	analysis	NOUN
ajst-1502	6	4	of	of	ADP
ajst-1502	6	5	the	the	DET
ajst-1502	6	6	risk	risk	NOUN
ajst-1502	6	7	of	of	ADP
ajst-1502	6	8	developing	develop	VERB
ajst-1502	6	9	hypertension	hypertension	NOUN
ajst-1502	6	10	at	at	ADP
ajst-1502	6	11	each	each	DET
ajst-1502	6	12	point	point	NOUN
ajst-1502	6	13	.	.	PUNCT
ajst-1502	7	1	results	result	NOUN
ajst-1502	7	2	:	:	PUNCT
ajst-1502	7	3	there	there	PRON
ajst-1502	7	4	were	be	VERB
ajst-1502	7	5	three	three	NUM
ajst-1502	7	6	genotypes	genotype	NOUN
ajst-1502	7	7	of	of	ADP
ajst-1502	7	8	c	c	PROPN
ajst-1502	7	9	/	/	SYM
ajst-1502	7	10	c	c	NOUN
ajst-1502	7	11	,	,	PUNCT
ajst-1502	7	12	c	c	NOUN
ajst-1502	7	13	/	/	SYM
ajst-1502	7	14	t	t	PROPN
ajst-1502	7	15	and	and	CCONJ
ajst-1502	7	16	t	t	PROPN
ajst-1502	7	17	/	/	SYM
ajst-1502	7	18	t	t	PROPN
ajst-1502	7	19	in	in	ADP
ajst-1502	7	20	the	the	DET
ajst-1502	7	21	il-10	il-10	PRON
ajst-1502	7	22	-	-	PUNCT
ajst-1502	7	23	819	819	NUM
ajst-1502	7	24	locus	locus	NOUN
ajst-1502	7	25	.	.	PUNCT
ajst-1502	8	1	there	there	PRON
ajst-1502	8	2	was	be	VERB
ajst-1502	8	3	no	no	DET
ajst-1502	8	4	significant	significant	ADJ
ajst-1502	8	5	difference	difference	NOUN
ajst-1502	8	6	between	between	ADP
ajst-1502	8	7	the	the	DET
ajst-1502	8	8	two	two	NUM
ajst-1502	8	9	groups	group	NOUN
ajst-1502	8	10	(	(	PUNCT
ajst-1502	8	11	p>0.05	p>0.05	PROPN
ajst-1502	8	12	)	)	PUNCT
ajst-1502	8	13	.	.	PUNCT
ajst-1502	9	1	there	there	PRON
ajst-1502	9	2	were	be	VERB
ajst-1502	9	3	g	g	NOUN
ajst-1502	9	4	/	/	SYM
ajst-1502	9	5	g	g	NOUN
ajst-1502	9	6	,	,	PUNCT
ajst-1502	9	7	g	g	NOUN
ajst-1502	9	8	/	/	SYM
ajst-1502	9	9	a	a	NOUN
ajst-1502	9	10	and	and	CCONJ
ajst-1502	9	11	a	a	PRON
ajst-1502	9	12	/	/	SYM
ajst-1502	9	13	a	a	DET
ajst-1502	9	14	genotypes	genotype	NOUN
ajst-1502	9	15	in	in	ADP
ajst-1502	9	16	il-10	il-10	PRON
ajst-1502	9	17	-	-	SYM
ajst-1502	9	18	1082	1082	NUM
ajst-1502	9	19	loci	locus	NOUN
ajst-1502	9	20	in	in	ADP
ajst-1502	9	21	both	both	DET
ajst-1502	9	22	groups	group	NOUN
ajst-1502	9	23	.	.	PUNCT
ajst-1502	10	1	there	there	PRON
ajst-1502	10	2	was	be	VERB
ajst-1502	10	3	no	no	DET
ajst-1502	10	4	significant	significant	ADJ
ajst-1502	10	5	difference	difference	NOUN
ajst-1502	10	6	between	between	ADP
ajst-1502	10	7	the	the	DET
ajst-1502	10	8	two	two	NUM
ajst-1502	10	9	groups	group	NOUN
ajst-1502	10	10	(	(	PUNCT
ajst-1502	10	11	p>0.05	p>0.05	PROPN
ajst-1502	10	12	)	)	PUNCT
ajst-1502	10	13	.	.	PUNCT
ajst-1502	11	1	logistic	logistic	ADJ
ajst-1502	11	2	regression	regression	NOUN
ajst-1502	11	3	analysis	analysis	NOUN
ajst-1502	11	4	showed	show	VERB
ajst-1502	11	5	that	that	SCONJ
ajst-1502	11	6	compared	compare	VERB
ajst-1502	11	7	with	with	ADP
ajst-1502	11	8	il-10	il-10	PRON
ajst-1502	11	9	-	-	PUNCT
ajst-1502	11	10	819c	819c	VERB
ajst-1502	11	11	/	/	SYM
ajst-1502	11	12	c	c	NOUN
ajst-1502	11	13	genotype	genotype	NOUN
ajst-1502	11	14	,	,	PUNCT
ajst-1502	11	15	the	the	DET
ajst-1502	11	16	risk	risk	NOUN
ajst-1502	11	17	of	of	ADP
ajst-1502	11	18	hypertension	hypertension	NOUN
ajst-1502	11	19	in	in	ADP
ajst-1502	11	20	the	the	DET
ajst-1502	11	21	population	population	NOUN
ajst-1502	11	22	carrying	carry	VERB
ajst-1502	11	23	il10	il10	PROPN
ajst-1502	11	24	-	-	PUNCT
ajst-1502	11	25	819c	819c	VERB
ajst-1502	11	26	/	/	SYM
ajst-1502	11	27	t	t	PROPN
ajst-1502	11	28	and	and	CCONJ
ajst-1502	11	29	t	t	PROPN
ajst-1502	11	30	/	/	SYM
ajst-1502	11	31	t	t	PROPN
ajst-1502	11	32	genotypes	genotype	NOUN
ajst-1502	11	33	was	be	AUX
ajst-1502	11	34	or＝1.19	or＝1.19	ADJ
ajst-1502	11	35	(	(	PUNCT
ajst-1502	11	36	95%ci＝0.71~1.05	95%ci＝0.71~1.05	NOUN
ajst-1502	11	37	)	)	PUNCT
ajst-1502	11	38	,	,	PUNCT
ajst-1502	11	39	χ２=0.73	χ２=0.73	ADJ
ajst-1502	11	40	,	,	PUNCT
ajst-1502	11	41	p>0.05	p>0.05	NOUN
ajst-1502	11	42	,	,	PUNCT
ajst-1502	11	43	or＝1.05	or＝1.05	NOUN
ajst-1502	11	44	(	(	PUNCT
ajst-1502	11	45	95%ci＝1.01~1.10	95%ci＝1.01~1.10	NUM
ajst-1502	11	46	)	)	PUNCT
ajst-1502	11	47	,	,	PUNCT
ajst-1502	12	1	χ２	χ２	NOUN
ajst-1502	12	2	=	=	NOUN
ajst-1502	12	3	0.96,p>0.05	0.96,p>0.05	NUM
ajst-1502	12	4	,	,	PUNCT
ajst-1502	12	5	the	the	DET
ajst-1502	12	6	difference	difference	NOUN
ajst-1502	12	7	was	be	AUX
ajst-1502	12	8	not	not	PART
ajst-1502	12	9	statistically	statistically	ADV
ajst-1502	12	10	significant	significant	ADJ
ajst-1502	12	11	(	(	PUNCT
ajst-1502	12	12	p>0.05	p>0.05	PROPN
ajst-1502	12	13	)	)	PUNCT
ajst-1502	12	14	.	.	PUNCT
ajst-1502	13	1	compared	compare	VERB
ajst-1502	13	2	with	with	ADP
ajst-1502	13	3	il-10	il-10	PRON
ajst-1502	13	4	-	-	PUNCT
ajst-1502	13	5	1082a	1082a	NUM
ajst-1502	13	6	/	/	SYM
ajst-1502	13	7	a	a	PRON
ajst-1502	13	8	,	,	PUNCT
ajst-1502	13	9	the	the	DET
ajst-1502	13	10	risk	risk	NOUN
ajst-1502	13	11	of	of	ADP
ajst-1502	13	12	developing	develop	VERB
ajst-1502	13	13	hypertension	hypertension	NOUN
ajst-1502	13	14	in	in	ADP
ajst-1502	13	15	the	the	DET
ajst-1502	13	16	population	population	NOUN
ajst-1502	13	17	expressing	express	VERB
ajst-1502	13	18	il-10	il-10	NOUN
ajst-1502	13	19	-	-	SYM
ajst-1502	13	20	1082g	1082g	NUM
ajst-1502	13	21	/	/	SYM
ajst-1502	13	22	a	a	PRON
ajst-1502	13	23	and	and	CCONJ
ajst-1502	13	24	g	g	NOUN
ajst-1502	13	25	/	/	SYM
ajst-1502	13	26	g	g	NOUN
ajst-1502	13	27	genotypes	genotype	NOUN
ajst-1502	13	28	was	be	AUX
ajst-1502	13	29	or＝1.2	or＝1.2	ADJ
ajst-1502	13	30	(	(	PUNCT
ajst-1502	13	31	95%ci＝0.76~1.12	95%ci＝0.76~1.12	NUM
ajst-1502	13	32	)	)	PUNCT
ajst-1502	13	33	,	,	PUNCT
ajst-1502	13	34	χ２=0.704	χ２=0.704	NUM
ajst-1502	13	35	,	,	PUNCT
ajst-1502	13	36	p>0.05	p>0.05	NOUN
ajst-1502	13	37	,	,	PUNCT
ajst-1502	13	38	or＝1.33	or＝1.33	NOUN
ajst-1502	13	39	(	(	PUNCT
ajst-1502	13	40	95	95	NUM
ajst-1502	13	41	%	%	NOUN
ajst-1502	13	42	ci＝0.77~1.33	ci＝0.77~1.33	NOUN
ajst-1502	13	43	)	)	PUNCT
ajst-1502	13	44	,	,	PUNCT
ajst-1502	13	45	χ２=0.97	χ２=0.97	NOUN
ajst-1502	13	46	,	,	PUNCT
ajst-1502	13	47	p>0.05	p>0.05	PROPN
ajst-1502	13	48	,	,	PUNCT
ajst-1502	13	49	the	the	DET
ajst-1502	13	50	difference	difference	NOUN
ajst-1502	13	51	was	be	AUX
ajst-1502	13	52	not	not	PART
ajst-1502	13	53	statistically	statistically	ADV
ajst-1502	13	54	significant	significant	ADJ
ajst-1502	13	55	(	(	PUNCT
ajst-1502	13	56	p>0.05	p>0.05	PROPN
ajst-1502	13	57	)	)	PUNCT
ajst-1502	13	58	.	.	PUNCT
ajst-1502	14	1	conclusion	conclusion	NOUN
ajst-1502	14	2	:	:	PUNCT
ajst-1502	14	3	the	the	DET
ajst-1502	14	4	distribution	distribution	NOUN
ajst-1502	14	5	of	of	ADP
ajst-1502	14	6	genotypes	genotype	NOUN
ajst-1502	14	7	and	and	CCONJ
ajst-1502	14	8	alleles	allele	NOUN
ajst-1502	14	9	of	of	ADP
ajst-1502	14	10	il-10	il-10	NOUN
ajst-1502	14	11	-	-	PUNCT
ajst-1502	14	12	819	819	NUM
ajst-1502	14	13	and	and	CCONJ
ajst-1502	14	14	-1082	-1082	PROPN
ajst-1502	14	15	loci	loci	PROPN
ajst-1502	14	16	in	in	ADP
ajst-1502	14	17	han	han	PROPN
ajst-1502	14	18	patients	patient	NOUN
ajst-1502	14	19	with	with	ADP
ajst-1502	14	20	hypertension	hypertension	NOUN
ajst-1502	14	21	and	and	CCONJ
ajst-1502	14	22	healthy	healthy	ADJ
ajst-1502	14	23	people	people	NOUN
ajst-1502	14	24	in	in	ADP
ajst-1502	14	25	jianghan	jianghan	PROPN
ajst-1502	14	26	plain	plain	PROPN
ajst-1502	14	27	is	be	AUX
ajst-1502	14	28	similar	similar	ADJ
ajst-1502	14	29	,	,	PUNCT
ajst-1502	14	30	and	and	CCONJ
ajst-1502	14	31	the	the	DET
ajst-1502	14	32	genotype	genotype	NOUN
ajst-1502	14	33	mutations	mutation	NOUN
ajst-1502	14	34	of	of	ADP
ajst-1502	14	35	il-10	il-10	NOUN
ajst-1502	14	36	-	-	PUNCT
ajst-1502	14	37	819	819	NUM
ajst-1502	14	38	and	and	CCONJ
ajst-1502	14	39	-1082	-1082	PROPN
ajst-1502	14	40	are	be	AUX
ajst-1502	14	41	irrelevant	irrelevant	ADJ
ajst-1502	14	42	with	with	ADP
ajst-1502	14	43	hypertension	hypertension	NOUN
ajst-1502	14	44	.	.	PUNCT
ajst-1502	15	1	keywords	keyword	NOUN
ajst-1502	15	2	:	:	PUNCT
ajst-1502	15	3	iinterleukin-10	iinterleukin-10	ADJ
ajst-1502	15	4	,	,	PUNCT
ajst-1502	15	5	hypertension	hypertension	NOUN
ajst-1502	15	6	,	,	PUNCT
ajst-1502	15	7	gene	gene	NOUN
ajst-1502	15	8	polymorphism	polymorphism	NOUN
ajst-1502	15	9	,	,	PUNCT
ajst-1502	15	10	han	han	PROPN
ajst-1502	15	11	nationality	nationality	PROPN
ajst-1502	15	12	,	,	PUNCT
ajst-1502	15	13	chinese	chinese	PROPN
ajst-1502	15	14	.	.	PUNCT
ajst-1502	16	1	1	1	X
ajst-1502	16	2	.	.	X
ajst-1502	16	3	introduction	introduction	NOUN
ajst-1502	16	4	the	the	DET
ajst-1502	16	5	incidence	incidence	NOUN
ajst-1502	16	6	of	of	ADP
ajst-1502	16	7	hypertension	hypertension	NOUN
ajst-1502	16	8	is	be	AUX
ajst-1502	16	9	the	the	DET
ajst-1502	16	10	result	result	NOUN
ajst-1502	16	11	of	of	ADP
ajst-1502	16	12	the	the	DET
ajst-1502	16	13	participation	participation	NOUN
ajst-1502	16	14	of	of	ADP
ajst-1502	16	15	multiple	multiple	ADJ
ajst-1502	16	16	mechanisms	mechanism	NOUN
ajst-1502	16	17	.	.	PUNCT
ajst-1502	17	1	in	in	ADP
ajst-1502	17	2	addition	addition	NOUN
ajst-1502	17	3	to	to	ADP
ajst-1502	17	4	the	the	DET
ajst-1502	17	5	neuro	neuro	NOUN
ajst-1502	17	6	-	-	PUNCT
ajst-1502	17	7	endocrine	endocrine	NOUN
ajst-1502	17	8	mechanism	mechanism	NOUN
ajst-1502	17	9	of	of	ADP
ajst-1502	17	10	genetic	genetic	ADJ
ajst-1502	17	11	,	,	PUNCT
ajst-1502	17	12	dietary	dietary	ADJ
ajst-1502	17	13	,	,	PUNCT
ajst-1502	17	14	and	and	CCONJ
ajst-1502	17	15	mental	mental	ADJ
ajst-1502	17	16	emotions	emotion	NOUN
ajst-1502	17	17	,	,	PUNCT
ajst-1502	17	18	genetic	genetic	ADJ
ajst-1502	17	19	and	and	CCONJ
ajst-1502	17	20	inflammatory	inflammatory	ADJ
ajst-1502	17	21	mechanisms	mechanism	NOUN
ajst-1502	17	22	also	also	ADV
ajst-1502	17	23	play	play	VERB
ajst-1502	17	24	a	a	DET
ajst-1502	17	25	very	very	ADV
ajst-1502	17	26	important	important	ADJ
ajst-1502	17	27	role	role	NOUN
ajst-1502	17	28	[	[	X
ajst-1502	17	29	1	1	NUM
ajst-1502	17	30	]	]	PUNCT
ajst-1502	17	31	.	.	PUNCT
ajst-1502	18	1	in	in	ADP
ajst-1502	18	2	recent	recent	ADJ
ajst-1502	18	3	years	year	NOUN
ajst-1502	18	4	,	,	PUNCT
ajst-1502	18	5	several	several	ADJ
ajst-1502	18	6	studies	study	NOUN
ajst-1502	18	7	[	[	X
ajst-1502	18	8	2	2	NUM
ajst-1502	18	9	-	-	SYM
ajst-1502	18	10	3	3	NUM
ajst-1502	18	11	]	]	PUNCT
ajst-1502	18	12	found	find	VERB
ajst-1502	18	13	that	that	SCONJ
ajst-1502	18	14	hypertension	hypertension	NOUN
ajst-1502	18	15	is	be	AUX
ajst-1502	18	16	a	a	DET
ajst-1502	18	17	chronic	chronic	ADJ
ajst-1502	18	18	low	low	ADJ
ajst-1502	18	19	-	-	PUNCT
ajst-1502	18	20	level	level	NOUN
ajst-1502	18	21	inflammatory	inflammatory	ADJ
ajst-1502	18	22	process	process	NOUN
ajst-1502	18	23	,	,	PUNCT
ajst-1502	18	24	and	and	CCONJ
ajst-1502	18	25	cytokines	cytokine	NOUN
ajst-1502	18	26	play	play	VERB
ajst-1502	18	27	an	an	DET
ajst-1502	18	28	important	important	ADJ
ajst-1502	18	29	role	role	NOUN
ajst-1502	18	30	in	in	ADP
ajst-1502	18	31	the	the	DET
ajst-1502	18	32	process	process	NOUN
ajst-1502	18	33	of	of	ADP
ajst-1502	18	34	inflammation	inflammation	NOUN
ajst-1502	18	35	.	.	PUNCT
ajst-1502	19	1	inflammatory	inflammatory	ADJ
ajst-1502	19	2	factors	factor	NOUN
ajst-1502	19	3	are	be	AUX
ajst-1502	19	4	classified	classify	VERB
ajst-1502	19	5	into	into	ADP
ajst-1502	19	6	damaging	damaging	ADJ
ajst-1502	19	7	factors	factor	NOUN
ajst-1502	19	8	and	and	CCONJ
ajst-1502	19	9	protective	protective	ADJ
ajst-1502	19	10	factors	factor	NOUN
ajst-1502	19	11	,	,	PUNCT
ajst-1502	19	12	il-10	il-10	PRON
ajst-1502	19	13	.	.	PUNCT
ajst-1502	20	1	it	it	PRON
ajst-1502	20	2	is	be	AUX
ajst-1502	20	3	a	a	DET
ajst-1502	20	4	proven	prove	VERB
ajst-1502	20	5	anti	anti	ADJ
ajst-1502	20	6	-	-	ADJ
ajst-1502	20	7	inflammatory	inflammatory	ADJ
ajst-1502	20	8	cytokine	cytokine	NOUN
ajst-1502	20	9	whose	whose	DET
ajst-1502	20	10	physiological	physiological	ADJ
ajst-1502	20	11	function	function	NOUN
ajst-1502	20	12	is	be	AUX
ajst-1502	20	13	to	to	PART
ajst-1502	20	14	regulate	regulate	VERB
ajst-1502	20	15	the	the	DET
ajst-1502	20	16	immunosuppressive	immunosuppressive	ADJ
ajst-1502	20	17	function	function	NOUN
ajst-1502	20	18	of	of	ADP
ajst-1502	20	19	cells	cell	NOUN
ajst-1502	20	20	.	.	PUNCT
ajst-1502	21	1	studies	study	NOUN
ajst-1502	21	2	[	[	X
ajst-1502	21	3	4	4	X
ajst-1502	21	4	]	]	PUNCT
ajst-1502	21	5	have	have	AUX
ajst-1502	21	6	shown	show	VERB
ajst-1502	21	7	that	that	SCONJ
ajst-1502	21	8	serum	serum	NOUN
ajst-1502	21	9	levels	level	NOUN
ajst-1502	21	10	of	of	ADP
ajst-1502	21	11	il-10	il-10	NOUN
ajst-1502	21	12	are	be	AUX
ajst-1502	21	13	significantly	significantly	ADV
ajst-1502	21	14	elevated	elevate	VERB
ajst-1502	21	15	in	in	ADP
ajst-1502	21	16	patients	patient	NOUN
ajst-1502	21	17	with	with	ADP
ajst-1502	21	18	hypertension	hypertension	NOUN
ajst-1502	21	19	,	,	PUNCT
ajst-1502	21	20	suggesting	suggest	VERB
ajst-1502	21	21	that	that	SCONJ
ajst-1502	21	22	il-10	il-10	PRON
ajst-1502	21	23	may	may	AUX
ajst-1502	21	24	be	be	AUX
ajst-1502	21	25	involved	involve	VERB
ajst-1502	21	26	in	in	ADP
ajst-1502	21	27	the	the	DET
ajst-1502	21	28	pathogenesis	pathogenesis	NOUN
ajst-1502	21	29	of	of	ADP
ajst-1502	21	30	hypertension	hypertension	NOUN
ajst-1502	21	31	.	.	PUNCT
ajst-1502	22	1	the	the	DET
ajst-1502	22	2	biological	biological	ADJ
ajst-1502	22	3	function	function	NOUN
ajst-1502	22	4	and	and	CCONJ
ajst-1502	22	5	expression	expression	NOUN
ajst-1502	22	6	of	of	ADP
ajst-1502	22	7	il-10	il-10	NOUN
ajst-1502	22	8	are	be	AUX
ajst-1502	22	9	affected	affect	VERB
ajst-1502	22	10	by	by	ADP
ajst-1502	22	11	the	the	DET
ajst-1502	22	12	polymorphism	polymorphism	NOUN
ajst-1502	22	13	of	of	ADP
ajst-1502	22	14	the	the	DET
ajst-1502	22	15	promoter	promoter	NOUN
ajst-1502	22	16	region	region	NOUN
ajst-1502	22	17	of	of	ADP
ajst-1502	22	18	il-10	il-10	DET
ajst-1502	22	19	gene	gene	NOUN
ajst-1502	22	20	,	,	PUNCT
ajst-1502	22	21	and	and	CCONJ
ajst-1502	22	22	there	there	PRON
ajst-1502	22	23	is	be	VERB
ajst-1502	22	24	a	a	DET
ajst-1502	22	25	close	close	ADJ
ajst-1502	22	26	relationship	relationship	NOUN
ajst-1502	22	27	between	between	ADP
ajst-1502	22	28	the	the	DET
ajst-1502	22	29	polymorphic	polymorphic	ADJ
ajst-1502	22	30	site	site	NOUN
ajst-1502	22	31	of	of	ADP
ajst-1502	22	32	promoter	promoter	NOUN
ajst-1502	22	33	region	region	NOUN
ajst-1502	22	34	and	and	CCONJ
ajst-1502	22	35	transcriptional	transcriptional	ADJ
ajst-1502	22	36	regulator	regulator	NOUN
ajst-1502	22	37	.	.	PUNCT
ajst-1502	23	1	in	in	ADP
ajst-1502	23	2	this	this	DET
ajst-1502	23	3	study	study	NOUN
ajst-1502	23	4	,	,	PUNCT
ajst-1502	23	5	we	we	PRON
ajst-1502	23	6	selected	select	VERB
ajst-1502	23	7	the	the	DET
ajst-1502	23	8	polymorphisms	polymorphism	NOUN
ajst-1502	23	9	of	of	ADP
ajst-1502	23	10	-819	-819	PROPN
ajst-1502	23	11	and	and	CCONJ
ajst-1502	23	12	-1082	-1082	PROPN
ajst-1502	23	13	in	in	ADP
ajst-1502	23	14	the	the	DET
ajst-1502	23	15	il10	il10	PROPN
ajst-1502	23	16	promoter	promoter	NOUN
ajst-1502	23	17	region	region	NOUN
ajst-1502	23	18	of	of	ADP
ajst-1502	23	19	hypertensive	hypertensive	ADJ
ajst-1502	23	20	patients	patient	NOUN
ajst-1502	23	21	,	,	PUNCT
ajst-1502	23	22	and	and	CCONJ
ajst-1502	23	23	conducted	conduct	VERB
ajst-1502	23	24	statistical	statistical	ADJ
ajst-1502	23	25	analysis	analysis	NOUN
ajst-1502	23	26	by	by	ADP
ajst-1502	23	27	gene	gene	NOUN
ajst-1502	23	28	sequencing	sequence	VERB
ajst-1502	23	29	to	to	PART
ajst-1502	23	30	demonstrate	demonstrate	VERB
ajst-1502	23	31	il-10	il-10	DET
ajst-1502	23	32	gene	gene	NOUN
ajst-1502	23	33	polymorphism	polymorphism	NOUN
ajst-1502	23	34	and	and	CCONJ
ajst-1502	23	35	hypertension	hypertension	NOUN
ajst-1502	23	36	.	.	PUNCT
ajst-1502	24	1	relationship	relationship	NOUN
ajst-1502	24	2	.	.	PUNCT
ajst-1502	25	1	2	2	X
ajst-1502	25	2	.	.	X
ajst-1502	25	3	materials	material	NOUN
ajst-1502	25	4	and	and	CCONJ
ajst-1502	25	5	methods	method	NOUN
ajst-1502	25	6	general	general	ADJ
ajst-1502	25	7	information	information	NOUN
ajst-1502	25	8	50	50	NUM
ajst-1502	25	9	cases	case	NOUN
ajst-1502	25	10	of	of	ADP
ajst-1502	25	11	han	han	PROPN
ajst-1502	25	12	patients	patient	NOUN
ajst-1502	25	13	with	with	ADP
ajst-1502	25	14	hypertension	hypertension	NOUN
ajst-1502	25	15	in	in	ADP
ajst-1502	25	16	jianghan	jianghan	PROPN
ajst-1502	25	17	plain	plain	PROPN
ajst-1502	25	18	,	,	PUNCT
ajst-1502	25	19	who	who	PRON
ajst-1502	25	20	were	be	AUX
ajst-1502	25	21	admitted	admit	VERB
ajst-1502	25	22	to	to	ADP
ajst-1502	25	23	our	our	PRON
ajst-1502	25	24	hospital	hospital	NOUN
ajst-1502	25	25	from	from	ADP
ajst-1502	25	26	may	may	PROPN
ajst-1502	25	27	2018	2018	NUM
ajst-1502	25	28	to	to	ADP
ajst-1502	25	29	june	june	PROPN
ajst-1502	25	30	2018	2018	NUM
ajst-1502	25	31	,	,	PUNCT
ajst-1502	25	32	were	be	AUX
ajst-1502	25	33	selected	select	VERB
ajst-1502	25	34	as	as	ADP
ajst-1502	25	35	experimental	experimental	ADJ
ajst-1502	25	36	groups(eg	groups(eg	NOUN
ajst-1502	25	37	)	)	PUNCT
ajst-1502	25	38	,	,	PUNCT
ajst-1502	25	39	including	include	VERB
ajst-1502	25	40	23	23	NUM
ajst-1502	25	41	males	male	NOUN
ajst-1502	25	42	and	and	CCONJ
ajst-1502	25	43	27	27	NUM
ajst-1502	25	44	females	female	NOUN
ajst-1502	25	45	,	,	PUNCT
ajst-1502	25	46	age	age	NOUN
ajst-1502	25	47	29	29	NUM
ajst-1502	25	48	-	-	SYM
ajst-1502	25	49	82	82	NUM
ajst-1502	25	50	years	year	NOUN
ajst-1502	25	51	old	old	ADJ
ajst-1502	25	52	,	,	PUNCT
ajst-1502	25	53	and	and	CCONJ
ajst-1502	25	54	average	average	ADJ
ajst-1502	25	55	(	(	PUNCT
ajst-1502	25	56	63.24±11.38	63.24±11.38	NOUN
ajst-1502	25	57	)	)	PUNCT
ajst-1502	25	58	years	year	NOUN
ajst-1502	25	59	old	old	ADJ
ajst-1502	25	60	.	.	PUNCT
ajst-1502	26	1	in	in	ADP
ajst-1502	26	2	addition	addition	NOUN
ajst-1502	26	3	,	,	PUNCT
ajst-1502	26	4	50	50	NUM
ajst-1502	26	5	blood	blood	NOUN
ajst-1502	26	6	samples	sample	NOUN
ajst-1502	26	7	from	from	ADP
ajst-1502	26	8	healthy	healthy	ADJ
ajst-1502	26	9	people	people	NOUN
ajst-1502	26	10	in	in	ADP
ajst-1502	26	11	the	the	DET
ajst-1502	26	12	same	same	ADJ
ajst-1502	26	13	period	period	NOUN
ajst-1502	26	14	were	be	AUX
ajst-1502	26	15	collected	collect	VERB
ajst-1502	26	16	as	as	ADP
ajst-1502	26	17	a	a	DET
ajst-1502	26	18	control	control	NOUN
ajst-1502	26	19	group(cg	group(cg	NOUN
ajst-1502	26	20	)	)	PUNCT
ajst-1502	26	21	,	,	PUNCT
ajst-1502	26	22	including	include	VERB
ajst-1502	26	23	26	26	NUM
ajst-1502	26	24	males	male	NOUN
ajst-1502	26	25	and	and	CCONJ
ajst-1502	26	26	24	24	NUM
ajst-1502	26	27	females	female	NOUN
ajst-1502	26	28	,	,	PUNCT
ajst-1502	26	29	age	age	NOUN
ajst-1502	26	30	32	32	NUM
ajst-1502	26	31	-	-	SYM
ajst-1502	26	32	82	82	NUM
ajst-1502	26	33	years	year	NOUN
ajst-1502	26	34	old	old	ADJ
ajst-1502	26	35	,	,	PUNCT
ajst-1502	26	36	and	and	CCONJ
ajst-1502	26	37	average	average	ADJ
ajst-1502	26	38	(	(	PUNCT
ajst-1502	26	39	62.82±11.41	62.82±11.41	NUM
ajst-1502	26	40	)	)	PUNCT
ajst-1502	26	41	years	year	NOUN
ajst-1502	26	42	old	old	ADJ
ajst-1502	26	43	.	.	PUNCT
ajst-1502	27	1	there	there	PRON
ajst-1502	27	2	were	be	VERB
ajst-1502	27	3	no	no	DET
ajst-1502	27	4	significant	significant	ADJ
ajst-1502	27	5	differences	difference	NOUN
ajst-1502	27	6	between	between	ADP
ajst-1502	27	7	the	the	DET
ajst-1502	27	8	two	two	NUM
ajst-1502	27	9	groups	group	NOUN
ajst-1502	27	10	in	in	ADP
ajst-1502	27	11	age	age	NOUN
ajst-1502	27	12	and	and	CCONJ
ajst-1502	27	13	gender	gender	NOUN
ajst-1502	27	14	(	(	PUNCT
ajst-1502	27	15	p=0.83	p=0.83	ADJ
ajst-1502	27	16	,	,	PUNCT
ajst-1502	27	17	t=0.211	t=0.211	NUM
ajst-1502	27	18	)	)	PUNCT
ajst-1502	27	19	.	.	PUNCT
ajst-1502	28	1	inclusion	inclusion	NOUN
ajst-1502	28	2	criteria	criterion	NOUN
ajst-1502	28	3	:	:	PUNCT
ajst-1502	28	4	(	(	PUNCT
ajst-1502	28	5	1	1	X
ajst-1502	28	6	)	)	PUNCT
ajst-1502	28	7	hypertension	hypertension	NOUN
ajst-1502	28	8	diagnosis	diagnosis	NOUN
ajst-1502	28	9	according	accord	VERB
ajst-1502	28	10	to	to	ADP
ajst-1502	28	11	the	the	DET
ajst-1502	28	12	2010	2010	NUM
ajst-1502	28	13	china	china	PROPN
ajst-1502	28	14	guidelines	guideline	NOUN
ajst-1502	28	15	for	for	ADP
ajst-1502	28	16	the	the	DET
ajst-1502	28	17	prevention	prevention	NOUN
ajst-1502	28	18	and	and	CCONJ
ajst-1502	28	19	treatment	treatment	NOUN
ajst-1502	28	20	of	of	ADP
ajst-1502	28	21	hypertension	hypertension	NOUN
ajst-1502	28	22	[	[	X
ajst-1502	28	23	5	5	NUM
ajst-1502	28	24	]	]	PUNCT
ajst-1502	28	25	;	;	PUNCT
ajst-1502	28	26	(	(	PUNCT
ajst-1502	28	27	2	2	X
ajst-1502	28	28	)	)	PUNCT
ajst-1502	28	29	patients	patient	NOUN
ajst-1502	28	30	agree	agree	VERB
ajst-1502	28	31	,	,	PUNCT
ajst-1502	28	32	signed	sign	VERB
ajst-1502	28	33	informed	informed	ADJ
ajst-1502	28	34	consent	consent	NOUN
ajst-1502	28	35	;	;	PUNCT
ajst-1502	28	36	(	(	PUNCT
ajst-1502	28	37	3	3	X
ajst-1502	28	38	)	)	PUNCT
ajst-1502	28	39	did	do	AUX
ajst-1502	28	40	not	not	PART
ajst-1502	28	41	use	use	VERB
ajst-1502	28	42	immunosuppressants	immunosuppressant	NOUN
ajst-1502	28	43	or	or	CCONJ
ajst-1502	28	44	immune	immune	ADJ
ajst-1502	28	45	enhancers	enhancer	NOUN
ajst-1502	28	46	;	;	PUNCT
ajst-1502	28	47	(	(	PUNCT
ajst-1502	28	48	4	4	X
ajst-1502	28	49	)	)	PUNCT
ajst-1502	28	50	no	no	DET
ajst-1502	28	51	autoimmune	autoimmune	ADJ
ajst-1502	28	52	diseases	disease	NOUN
ajst-1502	28	53	or	or	CCONJ
ajst-1502	28	54	viral	viral	ADJ
ajst-1502	28	55	infectious	infectious	ADJ
ajst-1502	28	56	diseases	disease	NOUN
ajst-1502	28	57	;	;	PUNCT
ajst-1502	28	58	(	(	PUNCT
ajst-1502	28	59	5	5	X
ajst-1502	28	60	)	)	PUNCT
ajst-1502	28	61	no	no	DET
ajst-1502	28	62	obvious	obvious	ADJ
ajst-1502	28	63	damage	damage	NOUN
ajst-1502	28	64	to	to	ADP
ajst-1502	28	65	the	the	DET
ajst-1502	28	66	target	target	NOUN
ajst-1502	28	67	organs	organ	NOUN
ajst-1502	28	68	such	such	ADJ
ajst-1502	28	69	as	as	ADP
ajst-1502	28	70	heart	heart	NOUN
ajst-1502	28	71	,	,	PUNCT
ajst-1502	28	72	eyes	eye	NOUN
ajst-1502	28	73	,	,	PUNCT
ajst-1502	28	74	kidney	kidney	NOUN
ajst-1502	28	75	,	,	PUNCT
ajst-1502	28	76	brain	brain	NOUN
ajst-1502	28	77	.	.	PUNCT
ajst-1502	29	1	exclusion	exclusion	NOUN
ajst-1502	29	2	criteria:(1	criteria:(1	NOUN
ajst-1502	29	3	)	)	PUNCT
ajst-1502	29	4	secondary	secondary	ADJ
ajst-1502	29	5	hypertension	hypertension	NOUN
ajst-1502	29	6	;	;	PUNCT
ajst-1502	29	7	(	(	PUNCT
ajst-1502	29	8	2	2	X
ajst-1502	29	9	)	)	PUNCT
ajst-1502	29	10	patients	patient	NOUN
ajst-1502	29	11	do	do	AUX
ajst-1502	29	12	not	not	PART
ajst-1502	29	13	cooperate	cooperate	VERB
ajst-1502	29	14	;	;	PUNCT
ajst-1502	29	15	(	(	PUNCT
ajst-1502	29	16	3	3	X
ajst-1502	29	17	)	)	PUNCT
ajst-1502	29	18	use	use	VERB
ajst-1502	29	19	immunosuppressants	immunosuppressant	NOUN
ajst-1502	29	20	or	or	CCONJ
ajst-1502	29	21	immune	immune	ADJ
ajst-1502	29	22	enhancers	enhancer	NOUN
ajst-1502	29	23	;	;	PUNCT
ajst-1502	29	24	(	(	PUNCT
ajst-1502	29	25	4	4	X
ajst-1502	29	26	)	)	PUNCT
ajst-1502	29	27	have	have	VERB
ajst-1502	29	28	autoimmune	autoimmune	ADJ
ajst-1502	29	29	diseases	disease	NOUN
ajst-1502	29	30	or	or	CCONJ
ajst-1502	29	31	viral	viral	ADJ
ajst-1502	29	32	infectious	infectious	ADJ
ajst-1502	29	33	diseases	disease	NOUN
ajst-1502	29	34	.	.	PUNCT
ajst-1502	30	1	the	the	DET
ajst-1502	30	2	study	study	NOUN
ajst-1502	30	3	was	be	AUX
ajst-1502	30	4	approved	approve	VERB
ajst-1502	30	5	by	by	ADP
ajst-1502	30	6	the	the	DET
ajst-1502	30	7	hospital	hospital	NOUN
ajst-1502	30	8	medical	medical	ADJ
ajst-1502	30	9	ethics	ethic	NOUN
ajst-1502	30	10	committee	committee	NOUN
ajst-1502	30	11	.	.	PUNCT
ajst-1502	31	1	2.1	2.1	NUM
ajst-1502	31	2	method	method	NOUN
ajst-1502	31	3	2.1.1	2.1.1	NUM
ajst-1502	31	4	dna	dna	NOUN
ajst-1502	31	5	extraction	extraction	NOUN
ajst-1502	31	6	and	and	CCONJ
ajst-1502	31	7	primer	primer	NOUN
ajst-1502	31	8	preparation	preparation	NOUN
ajst-1502	31	9	2ml	2ml	NOUN
ajst-1502	31	10	of	of	ADP
ajst-1502	31	11	fasting	fast	VERB
ajst-1502	31	12	blood	blood	NOUN
ajst-1502	31	13	in	in	ADP
ajst-1502	31	14	the	the	DET
ajst-1502	31	15	morning	morning	NOUN
ajst-1502	31	16	,	,	PUNCT
ajst-1502	31	17	edta	edta	NOUN
ajst-1502	31	18	anticoagulation	anticoagulation	NOUN
ajst-1502	31	19	,	,	PUNCT
ajst-1502	31	20	dna	dna	NOUN
ajst-1502	31	21	extraction	extraction	NOUN
ajst-1502	31	22	using	use	VERB
ajst-1502	31	23	whole	whole	ADJ
ajst-1502	31	24	blood	blood	NOUN
ajst-1502	31	25	genome	genome	NOUN
ajst-1502	31	26	low	low	ADJ
ajst-1502	31	27	-	-	PUNCT
ajst-1502	31	28	dose	dose	NOUN
ajst-1502	31	29	kit	kit	NOUN
ajst-1502	31	30	,	,	PUNCT
ajst-1502	31	31	dna	dna	NOUN
ajst-1502	31	32	quality	quality	NOUN
ajst-1502	31	33	detection	detection	NOUN
ajst-1502	31	34	and	and	CCONJ
ajst-1502	31	35	concentration	concentration	NOUN
ajst-1502	31	36	purification	purification	NOUN
ajst-1502	31	37	.	.	PUNCT
ajst-1502	32	1	primers	primer	NOUN
ajst-1502	32	2	were	be	AUX
ajst-1502	32	3	set	set	VERB
ajst-1502	32	4	according	accord	VERB
ajst-1502	32	5	to	to	ADP
ajst-1502	32	6	the	the	DET
ajst-1502	32	7	il-10	il-10	PRON
ajst-1502	32	8	promoter	promoter	NOUN
ajst-1502	32	9	sequence	sequence	NOUN
ajst-1502	32	10	,	,	PUNCT
ajst-1502	32	11	and	and	CCONJ
ajst-1502	32	12	the	the	DET
ajst-1502	32	13	primer	primer	NOUN
ajst-1502	32	14	sequence	sequence	NOUN
ajst-1502	32	15	was	be	AUX
ajst-1502	32	16	f	f	NOUN
ajst-1502	32	17	:	:	PUNCT
ajst-1502	32	18	gcaacactcctcgccgc	gcaacactcctcgccgc	NOUN
ajst-1502	32	19	;	;	PUNCT
ajst-1502	32	20	r	r	NOUN
ajst-1502	32	21	:	:	PUNCT
ajst-1502	32	22	taccccgatttcattaggattct	taccccgatttcattaggattct	NOUN
ajst-1502	32	23	.	.	PUNCT
ajst-1502	33	1	2.1.2	2.1.2	NUM
ajst-1502	33	2	pcr	pcr	ADJ
ajst-1502	33	3	amplification	amplification	NOUN
ajst-1502	33	4	and	and	CCONJ
ajst-1502	33	5	sequencing	sequence	VERB
ajst-1502	33	6	2.1.2.1	2.1.2.1	NUM
ajst-1502	33	7	sequencing	sequence	VERB
ajst-1502	33	8	pcr	pcr	ADJ
ajst-1502	33	9	reaction	reaction	NOUN
ajst-1502	33	10	.	.	PUNCT
ajst-1502	34	1	the	the	DET
ajst-1502	34	2	reagent	reagent	NOUN
ajst-1502	34	3	used	use	VERB
ajst-1502	34	4	was	be	AUX
ajst-1502	34	5	abi	abi	PROPN
ajst-1502	34	6	's	's	PART
ajst-1502	34	7	bdt3.1	bdt3.1	ADJ
ajst-1502	34	8	sequencing	sequence	VERB
ajst-1502	34	9	kit	kit	NOUN
ajst-1502	34	10	(	(	PUNCT
ajst-1502	34	11	bigdye	bigdye	NOUN
ajst-1502	34	12	terminator	terminator	NOUN
ajst-1502	34	13	v3.1	v3.1	ADP
ajst-1502	34	14	)	)	PUNCT
ajst-1502	34	15	,	,	PUNCT
ajst-1502	34	16	and	and	CCONJ
ajst-1502	34	17	the	the	DET
ajst-1502	34	18	sequencing	sequence	VERB
ajst-1502	34	19	reactions	reaction	NOUN
ajst-1502	34	20	were	be	AUX
ajst-1502	34	21	performed	perform	VERB
ajst-1502	34	22	according	accord	VERB
ajst-1502	34	23	to	to	ADP
ajst-1502	34	24	the	the	DET
ajst-1502	34	25	bdt3.1	bdt3.1	PROPN
ajst-1502	34	26	manual	manual	NOUN
ajst-1502	34	27	.	.	PUNCT
ajst-1502	35	1	2.1.2.2	2.1.2.2	NUM
ajst-1502	35	2	purification	purification	NOUN
ajst-1502	35	3	of	of	ADP
ajst-1502	35	4	sequencing	sequence	VERB
ajst-1502	35	5	pcr	pcr	ADJ
ajst-1502	35	6	products	product	NOUN
ajst-1502	35	7	.	.	PUNCT
ajst-1502	36	1	use	use	VERB
ajst-1502	36	2	the	the	DET
ajst-1502	36	3	85	85	NUM
ajst-1502	36	4	ethanol	ethanol	NOUN
ajst-1502	36	5	precipitation	precipitation	NOUN
ajst-1502	36	6	method	method	NOUN
ajst-1502	36	7	in	in	ADP
ajst-1502	36	8	the	the	DET
ajst-1502	36	9	bdt3.1	bdt3.1	PROPN
ajst-1502	36	10	manual	manual	NOUN
ajst-1502	36	11	,	,	PUNCT
ajst-1502	36	12	and	and	CCONJ
ajst-1502	36	13	store	store	VERB
ajst-1502	36	14	it	it	PRON
ajst-1502	36	15	at	at	ADP
ajst-1502	36	16	4	4	NUM
ajst-1502	36	17	°	°	ADP
ajst-1502	36	18	c	c	NOUN
ajst-1502	36	19	in	in	ADP
ajst-1502	36	20	the	the	DET
ajst-1502	36	21	dark	dark	NOUN
ajst-1502	36	22	after	after	ADP
ajst-1502	36	23	drying	dry	VERB
ajst-1502	36	24	.	.	PUNCT
ajst-1502	37	1	as	as	ADV
ajst-1502	37	2	long	long	ADV
ajst-1502	37	3	as	as	SCONJ
ajst-1502	37	4	the	the	DET
ajst-1502	37	5	seal	seal	NOUN
ajst-1502	37	6	is	be	AUX
ajst-1502	37	7	tightly	tightly	ADV
ajst-1502	37	8	stored	store	VERB
ajst-1502	37	9	for	for	ADP
ajst-1502	37	10	up	up	ADP
ajst-1502	37	11	to	to	PART
ajst-1502	37	12	one	one	NUM
ajst-1502	37	13	month	month	NOUN
ajst-1502	37	14	.	.	PUNCT
ajst-1502	38	1	2.1.2.3	2.1.2.3	NUM
ajst-1502	38	2	formamide	formamide	ADJ
ajst-1502	38	3	denaturation	denaturation	NOUN
ajst-1502	38	4	.	.	PUNCT
ajst-1502	39	1	10	10	NUM
ajst-1502	39	2	ul	ul	INTJ
ajst-1502	39	3	of	of	ADP
ajst-1502	39	4	formamide	formamide	ADV
ajst-1502	39	5	was	be	AUX
ajst-1502	39	6	added	add	VERB
ajst-1502	39	7	,	,	PUNCT
ajst-1502	39	8	and	and	CCONJ
ajst-1502	39	9	the	the	DET
ajst-1502	39	10	purified	purify	VERB
ajst-1502	39	11	dry	dry	ADJ
ajst-1502	39	12	powder	powder	NOUN
ajst-1502	39	13	was	be	AUX
ajst-1502	39	14	sufficiently	sufficiently	ADV
ajst-1502	39	15	dissolved	dissolve	VERB
ajst-1502	39	16	,	,	PUNCT
ajst-1502	39	17	followed	follow	VERB
ajst-1502	39	18	by	by	ADP
ajst-1502	39	19	being	be	AUX
ajst-1502	39	20	subjected	subject	VERB
ajst-1502	39	21	to	to	ADP
ajst-1502	39	22	a	a	DET
ajst-1502	39	23	denaturation	denaturation	NOUN
ajst-1502	39	24	reaction	reaction	NOUN
ajst-1502	39	25	in	in	ADP
ajst-1502	39	26	a	a	DET
ajst-1502	39	27	pcr	pcr	ADJ
ajst-1502	39	28	machine	machine	NOUN
ajst-1502	39	29	.	.	PUNCT
ajst-1502	40	1	2.1.2.4	2.1.2.4	NUM
ajst-1502	40	2	sample	sample	NOUN
ajst-1502	40	3	sequencing	sequencing	NOUN
ajst-1502	40	4	.	.	PUNCT
ajst-1502	41	1	the	the	DET
ajst-1502	41	2	denatured	denature	VERB
ajst-1502	41	3	samples	sample	NOUN
ajst-1502	41	4	were	be	AUX
ajst-1502	41	5	sequenced	sequence	VERB
ajst-1502	41	6	using	use	VERB
ajst-1502	41	7	3730xl	3730xl	NOUN
ajst-1502	41	8	.	.	PUNCT
ajst-1502	42	1	install	install	VERB
ajst-1502	42	2	the	the	DET
ajst-1502	42	3	capillary	capillary	ADJ
ajst-1502	42	4	according	accord	VERB
ajst-1502	42	5	to	to	ADP
ajst-1502	42	6	the	the	DET
ajst-1502	42	7	instrument	instrument	NOUN
ajst-1502	42	8	manual	manual	NOUN
ajst-1502	42	9	,	,	PUNCT
ajst-1502	42	10	perform	perform	VERB
ajst-1502	42	11	capillary	capillary	ADJ
ajst-1502	42	12	position	position	NOUN
ajst-1502	42	13	correction	correction	NOUN
ajst-1502	42	14	,	,	PUNCT
ajst-1502	42	15	manually	manually	ADV
ajst-1502	42	16	manually	manually	ADV
ajst-1502	42	17	fill	fill	VERB
ajst-1502	42	18	the	the	DET
ajst-1502	42	19	glue	glue	NOUN
ajst-1502	42	20	and	and	CCONJ
ajst-1502	42	21	create	create	VERB
ajst-1502	42	22	a	a	DET
ajst-1502	42	23	running	run	VERB
ajst-1502	42	24	sequencing	sequence	VERB
ajst-1502	42	25	sequence	sequence	NOUN
ajst-1502	42	26	file	file	NOUN
ajst-1502	42	27	.	.	PUNCT
ajst-1502	43	1	the	the	DET
ajst-1502	43	2	instrument	instrument	NOUN
ajst-1502	43	3	will	will	AUX
ajst-1502	43	4	automatically	automatically	ADV
ajst-1502	43	5	fill	fill	VERB
ajst-1502	43	6	the	the	DET
ajst-1502	43	7	gel	gel	NOUN
ajst-1502	43	8	to	to	ADP
ajst-1502	43	9	the	the	DET
ajst-1502	43	10	capillary	capillary	ADJ
ajst-1502	43	11	,	,	PUNCT
ajst-1502	43	12	pre	pre	ADJ
ajst-1502	43	13	-	-	NOUN
ajst-1502	43	14	electrophoresis	electrophoresis	NOUN
ajst-1502	43	15	for	for	ADP
ajst-1502	43	16	1.2	1.2	NUM
ajst-1502	43	17	min	min	NOUN
ajst-1502	43	18	at	at	ADP
ajst-1502	43	19	1.2	1.2	NUM
ajst-1502	43	20	kv	kv	NOUN
ajst-1502	43	21	,	,	PUNCT
ajst-1502	43	22	auto	auto	NOUN
ajst-1502	43	23	-	-	PUNCT
ajst-1502	43	24	inject	inject	NOUN
ajst-1502	43	25	in	in	ADP
ajst-1502	43	26	the	the	DET
ajst-1502	43	27	programmed	program	VERB
ajst-1502	43	28	order	order	NOUN
ajst-1502	43	29	,	,	PUNCT
ajst-1502	43	30	preelectrophoresis	preelectrophoresis	NOUN
ajst-1502	43	31	(	(	PUNCT
ajst-1502	43	32	1.2	1.2	NUM
ajst-1502	43	33	kv	kv	NOUN
ajst-1502	43	34	,	,	PUNCT
ajst-1502	43	35	20	20	NUM
ajst-1502	43	36	min	min	NOUN
ajst-1502	43	37	)	)	PUNCT
ajst-1502	43	38	,	,	PUNCT
ajst-1502	43	39	and	and	CCONJ
ajst-1502	43	40	electrophoresis	electrophoresis	NOUN
ajst-1502	43	41	at	at	ADP
ajst-1502	43	42	7.5	7.5	NUM
ajst-1502	43	43	kv	kv	NOUN
ajst-1502	43	44	for	for	ADP
ajst-1502	43	45	2	2	NUM
ajst-1502	43	46	h.	h.	NOUN
ajst-1502	43	47	after	after	SCONJ
ajst-1502	43	48	the	the	DET
ajst-1502	43	49	electrophoresis	electrophoresis	NOUN
ajst-1502	43	50	is	be	AUX
ajst-1502	43	51	finished	finish	VERB
ajst-1502	43	52	,	,	PUNCT
ajst-1502	43	53	the	the	DET
ajst-1502	43	54	instrument	instrument	NOUN
ajst-1502	43	55	will	will	AUX
ajst-1502	43	56	automatically	automatically	ADV
ajst-1502	43	57	clean	clean	VERB
ajst-1502	43	58	,	,	PUNCT
ajst-1502	43	59	fill	fill	VERB
ajst-1502	43	60	the	the	DET
ajst-1502	43	61	gel	gel	NOUN
ajst-1502	43	62	,	,	PUNCT
ajst-1502	43	63	enter	enter	VERB
ajst-1502	43	64	the	the	DET
ajst-1502	43	65	next	next	ADJ
ajst-1502	43	66	sample	sample	NOUN
ajst-1502	43	67	,	,	PUNCT
ajst-1502	43	68	pre	pre	ADJ
ajst-1502	43	69	-	-	NOUN
ajst-1502	43	70	electrophoresis	electrophoresis	NOUN
ajst-1502	43	71	and	and	CCONJ
ajst-1502	43	72	electrophoresis	electrophoresis	NOUN
ajst-1502	43	73	.	.	PUNCT
ajst-1502	44	1	the	the	DET
ajst-1502	44	2	total	total	ADJ
ajst-1502	44	3	time	time	NOUN
ajst-1502	44	4	of	of	ADP
ajst-1502	44	5	electrophoresis	electrophoresis	NOUN
ajst-1502	44	6	for	for	ADP
ajst-1502	44	7	each	each	DET
ajst-1502	44	8	sample	sample	NOUN
ajst-1502	44	9	was	be	AUX
ajst-1502	44	10	2.5	2.5	NUM
ajst-1502	44	11	h.	h.	NOUN
ajst-1502	44	12	the	the	DET
ajst-1502	44	13	color	color	NOUN
ajst-1502	44	14	sequencing	sequence	VERB
ajst-1502	44	15	map	map	NOUN
ajst-1502	44	16	is	be	AUX
ajst-1502	44	17	automatically	automatically	ADV
ajst-1502	44	18	printed	print	VERB
ajst-1502	44	19	after	after	ADP
ajst-1502	44	20	the	the	DET
ajst-1502	44	21	end	end	NOUN
ajst-1502	44	22	of	of	ADP
ajst-1502	44	23	electrophoresis	electrophoresis	NOUN
ajst-1502	44	24	.	.	PUNCT
ajst-1502	45	1	2.1.3	2.1.3	NUM
ajst-1502	45	2	sequence	sequence	NOUN
ajst-1502	45	3	analysis	analysis	NOUN
ajst-1502	45	4	,	,	PUNCT
ajst-1502	45	5	compare	compare	VERB
ajst-1502	45	6	the	the	DET
ajst-1502	45	7	sequence	sequence	NOUN
ajst-1502	45	8	difference	difference	NOUN
ajst-1502	45	9	of	of	ADP
ajst-1502	45	10	-819	-819	PROPN
ajst-1502	45	11	,	,	PUNCT
ajst-1502	45	12	-1082	-1082	PROPN
ajst-1502	45	13	between	between	ADP
ajst-1502	45	14	the	the	DET
ajst-1502	45	15	two	two	NUM
ajst-1502	45	16	groups	group	NOUN
ajst-1502	45	17	of	of	ADP
ajst-1502	45	18	il-10	il-10	DET
ajst-1502	45	19	promoter	promoter	NOUN
ajst-1502	45	20	regions	region	NOUN
ajst-1502	45	21	.	.	PUNCT
ajst-1502	46	1	2.2	2.2	NUM
ajst-1502	46	2	statistical	statistical	ADJ
ajst-1502	46	3	analysis	analysis	NOUN
ajst-1502	46	4	count	count	NOUN
ajst-1502	46	5	data	datum	NOUN
ajst-1502	46	6	were	be	AUX
ajst-1502	46	7	analyzed	analyze	VERB
ajst-1502	46	8	by	by	ADP
ajst-1502	46	9	χ2	χ2	PROPN
ajst-1502	46	10	test	test	NOUN
ajst-1502	46	11	,	,	PUNCT
ajst-1502	46	12	and	and	CCONJ
ajst-1502	46	13	logistic	logistic	ADJ
ajst-1502	46	14	regression	regression	NOUN
ajst-1502	46	15	was	be	AUX
ajst-1502	46	16	used	use	VERB
ajst-1502	46	17	to	to	PART
ajst-1502	46	18	analyze	analyze	VERB
ajst-1502	46	19	the	the	DET
ajst-1502	46	20	correlation	correlation	NOUN
ajst-1502	46	21	between	between	ADP
ajst-1502	46	22	each	each	DET
ajst-1502	46	23	genotype	genotype	NOUN
ajst-1502	46	24	and	and	CCONJ
ajst-1502	46	25	hypertension	hypertension	NOUN
ajst-1502	46	26	.	.	PUNCT
ajst-1502	47	1	the	the	DET
ajst-1502	47	2	test	test	NOUN
ajst-1502	47	3	standard	standard	NOUN
ajst-1502	47	4	is	be	AUX
ajst-1502	47	5	α	α	NOUN
ajst-1502	47	6	=	=	NOUN
ajst-1502	47	7	0.05	0.05	NUM
ajst-1502	47	8	.	.	PUNCT
ajst-1502	48	1	3	3	NUM
ajst-1502	48	2	.	.	X
ajst-1502	48	3	experimental	experimental	ADJ
ajst-1502	48	4	result	result	NOUN
ajst-1502	48	5	3.1	3.1	NUM
ajst-1502	48	6	genotype	genotype	NOUN
ajst-1502	48	7	and	and	CCONJ
ajst-1502	48	8	frequency	frequency	NOUN
ajst-1502	48	9	distribution	distribution	NOUN
ajst-1502	48	10	:	:	PUNCT
ajst-1502	48	11	there	there	PRON
ajst-1502	48	12	were	be	VERB
ajst-1502	48	13	three	three	NUM
ajst-1502	48	14	genotypes	genotype	NOUN
ajst-1502	48	15	of	of	ADP
ajst-1502	48	16	c	c	PROPN
ajst-1502	48	17	/	/	SYM
ajst-1502	48	18	c	c	NOUN
ajst-1502	48	19	,	,	PUNCT
ajst-1502	48	20	c	c	NOUN
ajst-1502	48	21	/	/	SYM
ajst-1502	48	22	t	t	PROPN
ajst-1502	48	23	and	and	CCONJ
ajst-1502	48	24	t	t	PROPN
ajst-1502	48	25	/	/	SYM
ajst-1502	48	26	t	t	PROPN
ajst-1502	48	27	in	in	ADP
ajst-1502	48	28	il-10	il-10	PRON
ajst-1502	48	29	-	-	PUNCT
ajst-1502	48	30	819	819	NUM
ajst-1502	48	31	locus	locus	NOUN
ajst-1502	48	32	in	in	ADP
ajst-1502	48	33	the	the	DET
ajst-1502	48	34	two	two	NUM
ajst-1502	48	35	groups	group	NOUN
ajst-1502	48	36	,	,	PUNCT
ajst-1502	48	37	and	and	CCONJ
ajst-1502	48	38	the	the	DET
ajst-1502	48	39	distribution	distribution	NOUN
ajst-1502	48	40	was	be	AUX
ajst-1502	48	41	not	not	PART
ajst-1502	48	42	statistically	statistically	ADV
ajst-1502	48	43	significant	significant	ADJ
ajst-1502	48	44	(	(	PUNCT
ajst-1502	48	45	p>0.05	p>0.05	PROPN
ajst-1502	48	46	)	)	PUNCT
ajst-1502	48	47	.	.	PUNCT
ajst-1502	49	1	there	there	PRON
ajst-1502	49	2	were	be	VERB
ajst-1502	49	3	g	g	NOUN
ajst-1502	49	4	/	/	SYM
ajst-1502	49	5	g	g	NOUN
ajst-1502	49	6	,	,	PUNCT
ajst-1502	49	7	g	g	NOUN
ajst-1502	49	8	/	/	SYM
ajst-1502	49	9	a	a	NOUN
ajst-1502	49	10	and	and	CCONJ
ajst-1502	49	11	a	a	PRON
ajst-1502	49	12	/	/	SYM
ajst-1502	49	13	a	a	DET
ajst-1502	49	14	genotypes	genotype	NOUN
ajst-1502	49	15	in	in	ADP
ajst-1502	49	16	il-101082	il-101082	PROPN
ajst-1502	49	17	loci	locus	NOUN
ajst-1502	49	18	in	in	ADP
ajst-1502	49	19	two	two	NUM
ajst-1502	49	20	groups	group	NOUN
ajst-1502	49	21	,	,	PUNCT
ajst-1502	49	22	and	and	CCONJ
ajst-1502	49	23	the	the	DET
ajst-1502	49	24	distribution	distribution	NOUN
ajst-1502	49	25	was	be	AUX
ajst-1502	49	26	not	not	PART
ajst-1502	49	27	statistically	statistically	ADV
ajst-1502	49	28	significant	significant	ADJ
ajst-1502	49	29	(	(	PUNCT
ajst-1502	49	30	p>0.05	p>0.05	PROPN
ajst-1502	49	31	)	)	PUNCT
ajst-1502	49	32	.	.	PUNCT
ajst-1502	50	1	see	see	VERB
ajst-1502	50	2	table1.figure	table1.figure	NOUN
ajst-1502	50	3	1	1	NUM
ajst-1502	50	4	.	.	PUNCT
ajst-1502	50	5	table	table	NOUN
ajst-1502	50	6	1	1	NUM
ajst-1502	50	7	.	.	PUNCT
ajst-1502	50	8	genotype	genotype	NOUN
ajst-1502	50	9	and	and	CCONJ
ajst-1502	50	10	frequency	frequency	NOUN
ajst-1502	50	11	distribution	distribution	NOUN
ajst-1502	50	12	in	in	ADP
ajst-1502	50	13	the	the	DET
ajst-1502	50	14	groups	group	NOUN
ajst-1502	50	15	il-10	il-10	ADP
ajst-1502	50	16	-	-	PUNCT
ajst-1502	50	17	819	819	NUM
ajst-1502	50	18	allele	allele	NOUN
ajst-1502	50	19	il-10	il-10	PRON
ajst-1502	50	20	-	-	PUNCT
ajst-1502	50	21	1082	1082	NUM
ajst-1502	50	22	allele	allele	NOUN
ajst-1502	50	23	groups	group	NOUN
ajst-1502	50	24	numbers	number	NOUN
ajst-1502	50	25	of	of	ADP
ajst-1502	50	26	cases	case	NOUN
ajst-1502	50	27	c	c	X
ajst-1502	50	28	/	/	SYM
ajst-1502	50	29	c	c	NOUN
ajst-1502	50	30	c	c	PROPN
ajst-1502	50	31	/	/	SYM
ajst-1502	50	32	t	t	PROPN
ajst-1502	50	33	t	t	PROPN
ajst-1502	50	34	/	/	SYM
ajst-1502	50	35	t	t	PROPN
ajst-1502	50	36	c	c	PROPN
ajst-1502	50	37	t	t	PROPN
ajst-1502	50	38	g	g	PROPN
ajst-1502	50	39	/	/	SYM
ajst-1502	50	40	g	g	NOUN
ajst-1502	50	41	g	g	PROPN
ajst-1502	50	42	/	/	SYM
ajst-1502	50	43	a	a	DET
ajst-1502	50	44	a	a	NOUN
ajst-1502	50	45	/	/	SYM
ajst-1502	50	46	a	a	PRON
ajst-1502	50	47	g	g	NOUN
ajst-1502	50	48	a	a	DET
ajst-1502	50	49	cg	cg	NOUN
ajst-1502	50	50	50	50	NUM
ajst-1502	50	51	14(28	14(28	NUM
ajst-1502	50	52	%	%	NOUN
ajst-1502	50	53	)	)	PUNCT
ajst-1502	50	54	19(38	19(38	NUM
ajst-1502	50	55	%	%	NOUN
ajst-1502	50	56	)	)	PUNCT
ajst-1502	50	57	17(34	17(34	NUM
ajst-1502	50	58	%	%	NOUN
ajst-1502	50	59	)	)	PUNCT
ajst-1502	50	60	47(47	47(47	NUM
ajst-1502	50	61	%	%	NOUN
ajst-1502	50	62	)	)	PUNCT
ajst-1502	51	1	53(53	53(53	NUM
ajst-1502	51	2	%	%	NOUN
ajst-1502	51	3	)	)	PUNCT
ajst-1502	52	1	14(28	14(28	NUM
ajst-1502	52	2	%	%	NOUN
ajst-1502	52	3	)	)	PUNCT
ajst-1502	52	4	20(40	20(40	NUM
ajst-1502	52	5	%	%	NOUN
ajst-1502	52	6	)	)	PUNCT
ajst-1502	52	7	16(32	16(32	NUM
ajst-1502	52	8	%	%	NOUN
ajst-1502	52	9	)	)	PUNCT
ajst-1502	52	10	48(48	48(48	NUM
ajst-1502	52	11	%	%	NOUN
ajst-1502	52	12	)	)	PUNCT
ajst-1502	52	13	52(52	52(52	NUM
ajst-1502	52	14	%	%	NOUN
ajst-1502	52	15	)	)	PUNCT
ajst-1502	52	16	eg	eg	VERB
ajst-1502	52	17	50	50	NUM
ajst-1502	52	18	13(26	13(26	NUM
ajst-1502	52	19	%	%	NOUN
ajst-1502	52	20	)	)	PUNCT
ajst-1502	52	21	21(42	21(42	NOUN
ajst-1502	52	22	%	%	NOUN
ajst-1502	52	23	)	)	PUNCT
ajst-1502	53	1	16(32	16(32	NUM
ajst-1502	53	2	%	%	NOUN
ajst-1502	53	3	)	)	PUNCT
ajst-1502	53	4	47(47	47(47	NUM
ajst-1502	53	5	%	%	NOUN
ajst-1502	53	6	)	)	PUNCT
ajst-1502	54	1	53(53	53(53	NUM
ajst-1502	54	2	%	%	NOUN
ajst-1502	54	3	)	)	PUNCT
ajst-1502	54	4	15(30	15(30	NUM
ajst-1502	54	5	%	%	NOUN
ajst-1502	54	6	)	)	PUNCT
ajst-1502	54	7	21(42	21(42	NOUN
ajst-1502	54	8	%	%	NOUN
ajst-1502	54	9	)	)	PUNCT
ajst-1502	55	1	14(28	14(28	NUM
ajst-1502	55	2	%	%	NOUN
ajst-1502	55	3	)	)	PUNCT
ajst-1502	55	4	51(51	51(51	NUM
ajst-1502	55	5	%	%	NOUN
ajst-1502	55	6	)	)	PUNCT
ajst-1502	56	1	49(49	49(49	NOUN
ajst-1502	56	2	%	%	NOUN
ajst-1502	56	3	)	)	PUNCT
ajst-1502	56	4	figure	figure	NOUN
ajst-1502	56	5	1	1	NUM
ajst-1502	56	6	.	.	PUNCT
ajst-1502	56	7	genotype	genotype	NOUN
ajst-1502	56	8	distribution	distribution	NOUN
ajst-1502	56	9	3.2	3.2	NUM
ajst-1502	56	10	genotype	genotype	NOUN
ajst-1502	56	11	frequency	frequency	NOUN
ajst-1502	56	12	hardy	hardy	ADJ
ajst-1502	56	13	-	-	PUNCT
ajst-1502	56	14	weinberg	weinberg	PROPN
ajst-1502	56	15	equilibrium	equilibrium	NOUN
ajst-1502	56	16	test	test	NOUN
ajst-1502	56	17	:	:	PUNCT
ajst-1502	56	18	the	the	DET
ajst-1502	56	19	actual	actual	ADJ
ajst-1502	56	20	value	value	NOUN
ajst-1502	56	21	obtained	obtain	VERB
ajst-1502	56	22	in	in	ADP
ajst-1502	56	23	this	this	DET
ajst-1502	56	24	study	study	NOUN
ajst-1502	56	25	is	be	AUX
ajst-1502	56	26	compared	compare	VERB
ajst-1502	56	27	with	with	ADP
ajst-1502	56	28	the	the	DET
ajst-1502	56	29	predicted	predict	VERB
ajst-1502	56	30	value	value	NOUN
ajst-1502	56	31	,	,	PUNCT
ajst-1502	56	32	and	and	CCONJ
ajst-1502	56	33	the	the	DET
ajst-1502	56	34	χ2	χ2	PROPN
ajst-1502	56	35	test	test	NOUN
ajst-1502	56	36	conforms	conform	VERB
ajst-1502	56	37	to	to	ADP
ajst-1502	56	38	the	the	DET
ajst-1502	56	39	hardyweinberg	hardyweinberg	PROPN
ajst-1502	56	40	equilibrium	equilibrium	NOUN
ajst-1502	56	41	(	(	PUNCT
ajst-1502	56	42	p>0.05	p>0.05	PROPN
ajst-1502	56	43	)	)	PUNCT
ajst-1502	56	44	.	.	PUNCT
ajst-1502	57	1	it	it	PRON
ajst-1502	57	2	was	be	AUX
ajst-1502	57	3	confirmed	confirm	VERB
ajst-1502	57	4	that	that	SCONJ
ajst-1502	57	5	the	the	DET
ajst-1502	57	6	population	population	NOUN
ajst-1502	57	7	of	of	ADP
ajst-1502	57	8	this	this	DET
ajst-1502	57	9	study	study	NOUN
ajst-1502	57	10	accorded	accord	VERB
ajst-1502	57	11	with	with	ADP
ajst-1502	57	12	the	the	DET
ajst-1502	57	13	laws	law	NOUN
ajst-1502	57	14	of	of	ADP
ajst-1502	57	15	genetics	genetic	NOUN
ajst-1502	57	16	and	and	CCONJ
ajst-1502	57	17	was	be	AUX
ajst-1502	57	18	representative.see	representative.see	X
ajst-1502	57	19	table	table	NOUN
ajst-1502	57	20	2	2	NUM
ajst-1502	57	21	and	and	CCONJ
ajst-1502	57	22	3	3	NUM
ajst-1502	57	23	.	.	NOUN
ajst-1502	58	1	86	86	NUM
ajst-1502	58	2	table	table	NOUN
ajst-1502	58	3	2	2	NUM
ajst-1502	58	4	.	.	PUNCT
ajst-1502	58	5	frequency	frequency	NOUN
ajst-1502	58	6	balance	balance	NOUN
ajst-1502	58	7	test	test	NOUN
ajst-1502	58	8	of	of	ADP
ajst-1502	58	9	il-10	il-10	PRON
ajst-1502	58	10	-	-	PUNCT
ajst-1502	58	11	819	819	NUM
ajst-1502	58	12	loci	locus	NOUN
ajst-1502	58	13	in	in	ADP
ajst-1502	58	14	two	two	NUM
ajst-1502	58	15	groups	group	NOUN
ajst-1502	58	16	groups	group	NOUN
ajst-1502	58	17	numbers	number	NOUN
ajst-1502	58	18	of	of	ADP
ajst-1502	58	19	cases	case	NOUN
ajst-1502	58	20	c	c	X
ajst-1502	58	21	/	/	SYM
ajst-1502	58	22	c	c	NOUN
ajst-1502	58	23	c	c	PROPN
ajst-1502	58	24	/	/	SYM
ajst-1502	58	25	t	t	PROPN
ajst-1502	58	26	t	t	PROPN
ajst-1502	58	27	/	/	SYM
ajst-1502	58	28	t	t	PROPN
ajst-1502	58	29	χ2	χ2	PROPN
ajst-1502	58	30	p	p	PROPN
ajst-1502	58	31	value	value	NOUN
ajst-1502	58	32	the	the	DET
ajst-1502	58	33	cortrol	cortrol	NOUN
ajst-1502	58	34	group	group	NOUN
ajst-1502	58	35	50	50	NUM
ajst-1502	58	36	the	the	DET
ajst-1502	58	37	actual	actual	ADJ
ajst-1502	58	38	value	value	NOUN
ajst-1502	58	39	14	14	NUM
ajst-1502	58	40	19	19	NUM
ajst-1502	58	41	17	17	NUM
ajst-1502	58	42	1.44	1.44	NUM
ajst-1502	58	43	>	>	PUNCT
ajst-1502	58	44	0.05	0.05	NUM
ajst-1502	58	45	the	the	DET
ajst-1502	58	46	predicted	predict	VERB
ajst-1502	58	47	value	value	NOUN
ajst-1502	58	48	11	11	NUM
ajst-1502	58	49	25	25	NUM
ajst-1502	58	50	14	14	NUM
ajst-1502	58	51	the	the	DET
ajst-1502	58	52	text	text	NOUN
ajst-1502	58	53	group	group	NOUN
ajst-1502	58	54	50	50	NUM
ajst-1502	58	55	the	the	DET
ajst-1502	58	56	actual	actual	ADJ
ajst-1502	58	57	value	value	NOUN
ajst-1502	58	58	13	13	NUM
ajst-1502	58	59	21	21	NUM
ajst-1502	58	60	16	16	NUM
ajst-1502	58	61	0.99	0.99	NUM
ajst-1502	58	62	>	>	PUNCT
ajst-1502	58	63	0.05	0.05	NUM
ajst-1502	58	64	the	the	DET
ajst-1502	58	65	predicted	predict	VERB
ajst-1502	58	66	value	value	NOUN
ajst-1502	58	67	11	11	NUM
ajst-1502	58	68	25	25	NUM
ajst-1502	58	69	14	14	NUM
ajst-1502	58	70	table	table	NOUN
ajst-1502	58	71	3	3	NUM
ajst-1502	58	72	.	.	PUNCT
ajst-1502	58	73	frequency	frequency	NOUN
ajst-1502	58	74	balance	balance	NOUN
ajst-1502	58	75	test	test	NOUN
ajst-1502	58	76	of	of	ADP
ajst-1502	58	77	il-10	il-10	PRON
ajst-1502	58	78	-	-	SYM
ajst-1502	58	79	1082	1082	NUM
ajst-1502	58	80	loci	locus	NOUN
ajst-1502	58	81	in	in	ADP
ajst-1502	58	82	two	two	NUM
ajst-1502	58	83	groups	group	NOUN
ajst-1502	58	84	groups	group	NOUN
ajst-1502	58	85	numbers	number	NOUN
ajst-1502	58	86	of	of	ADP
ajst-1502	58	87	cases	case	NOUN
ajst-1502	58	88	g	g	ADP
ajst-1502	58	89	/	/	SYM
ajst-1502	58	90	g	g	NOUN
ajst-1502	58	91	g	g	PROPN
ajst-1502	58	92	/	/	SYM
ajst-1502	58	93	a	a	DET
ajst-1502	58	94	a	a	NOUN
ajst-1502	58	95	/	/	SYM
ajst-1502	58	96	a	a	DET
ajst-1502	58	97	χ2	χ2	NOUN
ajst-1502	58	98	p	p	NOUN
ajst-1502	58	99	value	value	NOUN
ajst-1502	58	100	the	the	DET
ajst-1502	58	101	cortrol	cortrol	NOUN
ajst-1502	58	102	group	group	NOUN
ajst-1502	58	103	50	50	NUM
ajst-1502	58	104	the	the	DET
ajst-1502	58	105	actual	actual	ADJ
ajst-1502	58	106	value	value	NOUN
ajst-1502	58	107	14	14	NUM
ajst-1502	58	108	20	20	NUM
ajst-1502	58	109	16	16	NUM
ajst-1502	58	110	1.19	1.19	NUM
ajst-1502	58	111	>	>	SYM
ajst-1502	58	112	0.05	0.05	NUM
ajst-1502	58	113	the	the	DET
ajst-1502	58	114	predicted	predict	VERB
ajst-1502	58	115	value	value	NOUN
ajst-1502	58	116	12	12	NUM
ajst-1502	58	117	25	25	NUM
ajst-1502	58	118	13	13	NUM
ajst-1502	58	119	the	the	DET
ajst-1502	58	120	text	text	NOUN
ajst-1502	58	121	group	group	NOUN
ajst-1502	58	122	50	50	NUM
ajst-1502	58	123	the	the	DET
ajst-1502	58	124	actual	actual	ADJ
ajst-1502	58	125	value	value	NOUN
ajst-1502	58	126	15	15	NUM
ajst-1502	58	127	21	21	NUM
ajst-1502	58	128	14	14	NUM
ajst-1502	58	129	0.96	0.96	NUM
ajst-1502	58	130	>	>	PUNCT
ajst-1502	58	131	0.05	0.05	NUM
ajst-1502	58	132	the	the	DET
ajst-1502	58	133	predicted	predict	VERB
ajst-1502	58	134	value	value	NOUN
ajst-1502	58	135	13	13	NUM
ajst-1502	58	136	25	25	NUM
ajst-1502	58	137	12	12	NUM
ajst-1502	58	138	3.3	3.3	NUM
ajst-1502	58	139	correlation	correlation	NOUN
ajst-1502	58	140	analysis	analysis	NOUN
ajst-1502	58	141	between	between	ADP
ajst-1502	58	142	genetic	genetic	ADJ
ajst-1502	58	143	loci	locus	NOUN
ajst-1502	58	144	and	and	CCONJ
ajst-1502	58	145	breast	breast	NOUN
ajst-1502	58	146	cancer	cancer	NOUN
ajst-1502	58	147	genetic	genetic	ADJ
ajst-1502	58	148	susceptibility	susceptibility	NOUN
ajst-1502	58	149	.	.	PUNCT
ajst-1502	59	1	the	the	DET
ajst-1502	59	2	results	result	NOUN
ajst-1502	59	3	obtained	obtain	VERB
ajst-1502	59	4	in	in	ADP
ajst-1502	59	5	this	this	DET
ajst-1502	59	6	study	study	NOUN
ajst-1502	59	7	were	be	AUX
ajst-1502	59	8	analyzed	analyze	VERB
ajst-1502	59	9	by	by	ADP
ajst-1502	59	10	logistic	logistic	ADJ
ajst-1502	59	11	regression	regression	NOUN
ajst-1502	59	12	analysis	analysis	NOUN
ajst-1502	59	13	to	to	PART
ajst-1502	59	14	verify	verify	VERB
ajst-1502	59	15	the	the	DET
ajst-1502	59	16	correla	correla	NOUN
ajst-1502	59	17	-	-	PUNCT
ajst-1502	59	18	tion	tion	NOUN
ajst-1502	59	19	between	between	ADP
ajst-1502	59	20	il-10	il-10	NOUN
ajst-1502	59	21	-	-	PUNCT
ajst-1502	59	22	819	819	NUM
ajst-1502	59	23	and	and	CCONJ
ajst-1502	59	24	il-10	il-10	NUM
ajst-1502	59	25	-	-	SYM
ajst-1502	59	26	1082	1082	NUM
ajst-1502	59	27	points	point	NOUN
ajst-1502	59	28	and	and	CCONJ
ajst-1502	59	29	genetic	genetic	ADJ
ajst-1502	59	30	susceptibility	susceptibility	NOUN
ajst-1502	59	31	to	to	ADP
ajst-1502	59	32	hypertension.see	hypertension.see	NOUN
ajst-1502	59	33	table	table	NOUN
ajst-1502	59	34	4	4	NUM
ajst-1502	59	35	and	and	CCONJ
ajst-1502	59	36	5	5	NUM
ajst-1502	59	37	.	.	NOUN
ajst-1502	59	38	table	table	NOUN
ajst-1502	59	39	4	4	NUM
ajst-1502	59	40	.	.	PUNCT
ajst-1502	59	41	risk	risk	NOUN
ajst-1502	59	42	analysis	analysis	NOUN
ajst-1502	59	43	of	of	ADP
ajst-1502	59	44	genetic	genetic	ADJ
ajst-1502	59	45	predisposition	predisposition	NOUN
ajst-1502	59	46	of	of	ADP
ajst-1502	59	47	il-10	il-10	PRON
ajst-1502	59	48	-	-	PUNCT
ajst-1502	59	49	819	819	NUM
ajst-1502	59	50	locus	locus	NOUN
ajst-1502	59	51	polymorphism	polymorphism	NOUN
ajst-1502	59	52	in	in	ADP
ajst-1502	59	53	hypertension	hypertension	NOUN
ajst-1502	59	54	snp	snp	NOUN
ajst-1502	59	55	or	or	CCONJ
ajst-1502	59	56	95%ci	95%ci	NUM
ajst-1502	59	57	χ2	χ2	PROPN
ajst-1502	59	58	p	p	NOUN
ajst-1502	59	59	value	value	NOUN
ajst-1502	59	60	c	c	X
ajst-1502	59	61	/	/	SYM
ajst-1502	59	62	c	c	NOUN
ajst-1502	59	63	1	1	NUM
ajst-1502	59	64	c	c	X
ajst-1502	59	65	/	/	SYM
ajst-1502	59	66	t	t	PROPN
ajst-1502	59	67	1.19	1.19	NUM
ajst-1502	59	68	0.71—1.05	0.71—1.05	PROPN
ajst-1502	59	69	0.73	0.73	NUM
ajst-1502	59	70	>	>	NOUN
ajst-1502	59	71	0.05	0.05	NUM
ajst-1502	59	72	t	t	PROPN
ajst-1502	59	73	/	/	SYM
ajst-1502	59	74	t	t	PROPN
ajst-1502	59	75	1.05	1.05	NUM
ajst-1502	59	76	1.01—1.10	1.01—1.10	NUM
ajst-1502	59	77	0.96	0.96	NUM
ajst-1502	59	78	>	>	SYM
ajst-1502	59	79	0.05	0.05	NUM
ajst-1502	59	80	table	table	NOUN
ajst-1502	59	81	5	5	NUM
ajst-1502	59	82	.	.	PUNCT
ajst-1502	59	83	risk	risk	NOUN
ajst-1502	59	84	analysis	analysis	NOUN
ajst-1502	59	85	of	of	ADP
ajst-1502	59	86	genetic	genetic	ADJ
ajst-1502	59	87	predisposition	predisposition	NOUN
ajst-1502	59	88	of	of	ADP
ajst-1502	59	89	il-10	il-10	PRON
ajst-1502	59	90	-	-	PUNCT
ajst-1502	59	91	1082	1082	NUM
ajst-1502	59	92	locus	locus	NOUN
ajst-1502	59	93	polymorphism	polymorphism	NOUN
ajst-1502	59	94	in	in	ADP
ajst-1502	59	95	hypertension	hypertension	NOUN
ajst-1502	59	96	snp	snp	NOUN
ajst-1502	59	97	or	or	CCONJ
ajst-1502	59	98	95%ci	95%ci	NUM
ajst-1502	59	99	χ2	χ2	PROPN
ajst-1502	59	100	p	p	PROPN
ajst-1502	59	101	value	value	NOUN
ajst-1502	59	102	a	a	PRON
ajst-1502	59	103	/	/	SYM
ajst-1502	59	104	a	a	DET
ajst-1502	59	105	1	1	NUM
ajst-1502	59	106	g	g	NOUN
ajst-1502	59	107	/	/	SYM
ajst-1502	59	108	a	a	PRON
ajst-1502	59	109	1.2	1.2	NUM
ajst-1502	59	110	0.76	0.76	NUM
ajst-1502	59	111	-	-	SYM
ajst-1502	59	112	1.12	1.12	NUM
ajst-1502	59	113	0.704	0.704	NUM
ajst-1502	59	114	>	>	PUNCT
ajst-1502	59	115	0.05	0.05	NUM
ajst-1502	59	116	g	g	NOUN
ajst-1502	59	117	/	/	SYM
ajst-1502	59	118	g	g	NOUN
ajst-1502	59	119	1.33	1.33	NUM
ajst-1502	59	120	0.77	0.77	NUM
ajst-1502	59	121	-	-	SYM
ajst-1502	59	122	1.33	1.33	NUM
ajst-1502	59	123	0.97	0.97	NUM
ajst-1502	59	124	>	>	PUNCT
ajst-1502	59	125	0.05	0.05	NUM
ajst-1502	59	126	4	4	NUM
ajst-1502	59	127	.	.	PUNCT
ajst-1502	60	1	discuss	discuss	VERB
ajst-1502	60	2	there	there	PRON
ajst-1502	60	3	are	be	VERB
ajst-1502	60	4	many	many	ADJ
ajst-1502	60	5	factors	factor	NOUN
ajst-1502	60	6	involved	involve	VERB
ajst-1502	60	7	in	in	ADP
ajst-1502	60	8	the	the	DET
ajst-1502	60	9	occurrence	occurrence	NOUN
ajst-1502	60	10	and	and	CCONJ
ajst-1502	60	11	development	development	NOUN
ajst-1502	60	12	of	of	ADP
ajst-1502	60	13	hypertension	hypertension	NOUN
ajst-1502	60	14	.	.	PUNCT
ajst-1502	61	1	in	in	ADP
ajst-1502	61	2	addition	addition	NOUN
ajst-1502	61	3	to	to	ADP
ajst-1502	61	4	factors	factor	NOUN
ajst-1502	61	5	such	such	ADJ
ajst-1502	61	6	as	as	ADP
ajst-1502	61	7	renin	renin	ADJ
ajst-1502	61	8	angiotensin	angiotensin	NOUN
ajst-1502	61	9	system	system	NOUN
ajst-1502	61	10	,	,	PUNCT
ajst-1502	61	11	sympathetic	sympathetic	ADJ
ajst-1502	61	12	activation	activation	NOUN
ajst-1502	61	13	and	and	CCONJ
ajst-1502	61	14	high	high	ADJ
ajst-1502	61	15	salt	salt	NOUN
ajst-1502	61	16	diet	diet	NOUN
ajst-1502	61	17	,	,	PUNCT
ajst-1502	61	18	inflammation	inflammation	NOUN
ajst-1502	61	19	is	be	AUX
ajst-1502	61	20	also	also	ADV
ajst-1502	61	21	involved	involve	VERB
ajst-1502	61	22	in	in	ADP
ajst-1502	61	23	the	the	DET
ajst-1502	61	24	pathological	pathological	ADJ
ajst-1502	61	25	mechanism	mechanism	NOUN
ajst-1502	61	26	of	of	ADP
ajst-1502	61	27	hypertension	hypertension	NOUN
ajst-1502	61	28	,	,	PUNCT
ajst-1502	61	29	and	and	CCONJ
ajst-1502	61	30	cytokines	cytokine	NOUN
ajst-1502	61	31	are	be	AUX
ajst-1502	61	32	an	an	DET
ajst-1502	61	33	important	important	ADJ
ajst-1502	61	34	process	process	NOUN
ajst-1502	61	35	of	of	ADP
ajst-1502	61	36	inflammation	inflammation	NOUN
ajst-1502	61	37	.	.	PUNCT
ajst-1502	62	1	also	also	ADV
ajst-1502	62	2	involved	involve	VERB
ajst-1502	62	3	in	in	ADP
ajst-1502	62	4	the	the	DET
ajst-1502	62	5	pathogenesis	pathogenesis	NOUN
ajst-1502	62	6	and	and	CCONJ
ajst-1502	62	7	development	development	NOUN
ajst-1502	62	8	of	of	ADP
ajst-1502	62	9	hypertension	hypertension	NOUN
ajst-1502	62	10	.	.	PUNCT
ajst-1502	63	1	as	as	ADP
ajst-1502	63	2	an	an	DET
ajst-1502	63	3	important	important	ADJ
ajst-1502	63	4	antiinflammatory	antiinflammatory	NOUN
ajst-1502	63	5	cytokine	cytokine	NOUN
ajst-1502	63	6	,	,	PUNCT
ajst-1502	63	7	il-10	il-10	PRON
ajst-1502	63	8	is	be	AUX
ajst-1502	63	9	significantly	significantly	ADV
ajst-1502	63	10	elevated	elevate	VERB
ajst-1502	63	11	in	in	ADP
ajst-1502	63	12	the	the	DET
ajst-1502	63	13	serum	serum	NOUN
ajst-1502	63	14	of	of	ADP
ajst-1502	63	15	hypertensive	hypertensive	ADJ
ajst-1502	63	16	patients	patient	NOUN
ajst-1502	63	17	[	[	X
ajst-1502	63	18	4	4	NUM
ajst-1502	63	19	]	]	PUNCT
ajst-1502	63	20	,	,	PUNCT
ajst-1502	63	21	which	which	PRON
ajst-1502	63	22	is	be	AUX
ajst-1502	63	23	also	also	ADV
ajst-1502	63	24	bound	bind	VERB
ajst-1502	63	25	to	to	PART
ajst-1502	63	26	participate	participate	VERB
ajst-1502	63	27	in	in	ADP
ajst-1502	63	28	the	the	DET
ajst-1502	63	29	pathogenesis	pathogenesis	NOUN
ajst-1502	63	30	of	of	ADP
ajst-1502	63	31	hypertension	hypertension	NOUN
ajst-1502	63	32	.	.	PUNCT
ajst-1502	64	1	il-10	il-10	PRON
ajst-1502	64	2	belongs	belong	VERB
ajst-1502	64	3	to	to	ADP
ajst-1502	64	4	the	the	DET
ajst-1502	64	5	interferon	interferon	ADJ
ajst-1502	64	6	family	family	NOUN
ajst-1502	64	7	of	of	ADP
ajst-1502	64	8	cytokine	cytokine	ADJ
ajst-1502	64	9	synthesis	synthesis	NOUN
ajst-1502	64	10	inhibitors	inhibitor	NOUN
ajst-1502	64	11	[	[	X
ajst-1502	64	12	6	6	NUM
ajst-1502	64	13	]	]	PUNCT
ajst-1502	64	14	,	,	PUNCT
ajst-1502	64	15	which	which	PRON
ajst-1502	64	16	can	can	AUX
ajst-1502	64	17	act	act	VERB
ajst-1502	64	18	on	on	ADP
ajst-1502	64	19	mononuclear	mononuclear	ADJ
ajst-1502	64	20	-	-	PUNCT
ajst-1502	64	21	macrophages	macrophage	NOUN
ajst-1502	64	22	,	,	PUNCT
ajst-1502	64	23	inhibit	inhibit	VERB
ajst-1502	64	24	the	the	DET
ajst-1502	64	25	release	release	NOUN
ajst-1502	64	26	of	of	ADP
ajst-1502	64	27	immune	immune	ADJ
ajst-1502	64	28	mediators	mediator	NOUN
ajst-1502	64	29	,	,	PUNCT
ajst-1502	64	30	and	and	CCONJ
ajst-1502	64	31	reduce	reduce	VERB
ajst-1502	64	32	tnf	tnf	PROPN
ajst-1502	64	33	-	-	PUNCT
ajst-1502	64	34	α	α	PROPN
ajst-1502	64	35	,	,	PUNCT
ajst-1502	64	36	il-1	il-1	ADP
ajst-1502	64	37	,	,	PUNCT
ajst-1502	64	38	il-6	il-6	NOUN
ajst-1502	64	39	,	,	PUNCT
ajst-1502	64	40	il-8	il-8	NOUN
ajst-1502	64	41	,	,	PUNCT
ajst-1502	64	42	production	production	NOUN
ajst-1502	64	43	and	and	CCONJ
ajst-1502	64	44	secretion	secretion	NOUN
ajst-1502	64	45	of	of	ADP
ajst-1502	64	46	factors	factor	NOUN
ajst-1502	64	47	such	such	ADJ
ajst-1502	64	48	as	as	ADP
ajst-1502	64	49	il-12	il-12	NOUN
ajst-1502	64	50	[	[	X
ajst-1502	64	51	7	7	NUM
ajst-1502	64	52	]	]	PUNCT
ajst-1502	64	53	.	.	PUNCT
ajst-1502	65	1	il-10	il-10	NOUN
ajst-1502	65	2	also	also	ADV
ajst-1502	65	3	has	have	VERB
ajst-1502	65	4	the	the	DET
ajst-1502	65	5	ability	ability	NOUN
ajst-1502	65	6	to	to	PART
ajst-1502	65	7	inhibit	inhibit	VERB
ajst-1502	65	8	the	the	DET
ajst-1502	65	9	proliferation	proliferation	NOUN
ajst-1502	65	10	and	and	CCONJ
ajst-1502	65	11	migration	migration	NOUN
ajst-1502	65	12	of	of	ADP
ajst-1502	65	13	inflammatory	inflammatory	ADJ
ajst-1502	65	14	cells	cell	NOUN
ajst-1502	65	15	.	.	PUNCT
ajst-1502	66	1	in	in	ADP
ajst-1502	66	2	addition	addition	NOUN
ajst-1502	66	3	,	,	PUNCT
ajst-1502	66	4	il-10	il-10	PRON
ajst-1502	66	5	can	can	AUX
ajst-1502	66	6	also	also	ADV
ajst-1502	66	7	play	play	VERB
ajst-1502	66	8	an	an	DET
ajst-1502	66	9	important	important	ADJ
ajst-1502	66	10	role	role	NOUN
ajst-1502	66	11	in	in	ADP
ajst-1502	66	12	the	the	DET
ajst-1502	66	13	regulation	regulation	NOUN
ajst-1502	66	14	of	of	ADP
ajst-1502	66	15	vascular	vascular	ADJ
ajst-1502	66	16	endothelial	endothelial	ADJ
ajst-1502	66	17	cells	cell	NOUN
ajst-1502	66	18	in	in	ADP
ajst-1502	66	19	the	the	DET
ajst-1502	66	20	development	development	NOUN
ajst-1502	66	21	and	and	CCONJ
ajst-1502	66	22	progression	progression	NOUN
ajst-1502	66	23	of	of	ADP
ajst-1502	66	24	hypertension	hypertension	NOUN
ajst-1502	66	25	[	[	X
ajst-1502	66	26	8	8	NUM
ajst-1502	66	27	]	]	PUNCT
ajst-1502	66	28	.	.	PUNCT
ajst-1502	67	1	however	however	ADV
ajst-1502	67	2	,	,	PUNCT
ajst-1502	67	3	there	there	PRON
ajst-1502	67	4	are	be	VERB
ajst-1502	67	5	transcription	transcription	NOUN
ajst-1502	67	6	factors	factor	NOUN
ajst-1502	67	7	in	in	ADP
ajst-1502	67	8	the	the	DET
ajst-1502	67	9	promoter	promoter	NOUN
ajst-1502	67	10	region	region	NOUN
ajst-1502	67	11	of	of	ADP
ajst-1502	67	12	il-10	il-10	PRON
ajst-1502	67	13	,	,	PUNCT
ajst-1502	67	14	which	which	PRON
ajst-1502	67	15	affects	affect	VERB
ajst-1502	67	16	the	the	DET
ajst-1502	67	17	expression	expression	NOUN
ajst-1502	67	18	of	of	ADP
ajst-1502	67	19	its	its	PRON
ajst-1502	67	20	level	level	NOUN
ajst-1502	67	21	and	and	CCONJ
ajst-1502	67	22	further	far	ADV
ajst-1502	67	23	affects	affect	VERB
ajst-1502	67	24	its	its	PRON
ajst-1502	67	25	biological	biological	ADJ
ajst-1502	67	26	activity	activity	NOUN
ajst-1502	67	27	.	.	PUNCT
ajst-1502	68	1	therefore	therefore	ADV
ajst-1502	68	2	,	,	PUNCT
ajst-1502	68	3	the	the	DET
ajst-1502	68	4	study	study	NOUN
ajst-1502	68	5	of	of	ADP
ajst-1502	68	6	gene	gene	NOUN
ajst-1502	68	7	polymorphism	polymorphism	NOUN
ajst-1502	68	8	in	in	ADP
ajst-1502	68	9	promoter	promoter	NOUN
ajst-1502	68	10	region	region	NOUN
ajst-1502	68	11	is	be	AUX
ajst-1502	68	12	a	a	DET
ajst-1502	68	13	hot	hot	ADJ
ajst-1502	68	14	topic	topic	NOUN
ajst-1502	68	15	in	in	ADP
ajst-1502	68	16	current	current	ADJ
ajst-1502	68	17	research	research	NOUN
ajst-1502	68	18	.	.	PUNCT
ajst-1502	69	1	therefore	therefore	ADV
ajst-1502	69	2	,	,	PUNCT
ajst-1502	69	3	we	we	PRON
ajst-1502	69	4	also	also	ADV
ajst-1502	69	5	selected	select	VERB
ajst-1502	69	6	the	the	DET
ajst-1502	69	7	genetic	genetic	ADJ
ajst-1502	69	8	polymorphisms	polymorphism	NOUN
ajst-1502	69	9	of	of	ADP
ajst-1502	69	10	the	the	DET
ajst-1502	69	11	il-10	il-10	DET
ajst-1502	69	12	promoter	promoter	NOUN
ajst-1502	69	13	region	region	NOUN
ajst-1502	69	14	at	at	ADP
ajst-1502	69	15	-819	-819	PROPN
ajst-1502	69	16	and	and	CCONJ
ajst-1502	69	17	-1082	-1082	PROPN
ajst-1502	69	18	in	in	ADP
ajst-1502	69	19	hypertensive	hypertensive	ADJ
ajst-1502	69	20	patients	patient	NOUN
ajst-1502	69	21	,	,	PUNCT
ajst-1502	69	22	and	and	CCONJ
ajst-1502	69	23	conducted	conduct	VERB
ajst-1502	69	24	statistical	statistical	ADJ
ajst-1502	69	25	analysis	analysis	NOUN
ajst-1502	69	26	by	by	ADP
ajst-1502	69	27	gene	gene	NOUN
ajst-1502	69	28	sequencing	sequence	VERB
ajst-1502	69	29	to	to	PART
ajst-1502	69	30	demonstrate	demonstrate	VERB
ajst-1502	69	31	il-10	il-10	DET
ajst-1502	69	32	gene	gene	NOUN
ajst-1502	69	33	polymorphism	polymorphism	NOUN
ajst-1502	69	34	and	and	CCONJ
ajst-1502	69	35	hypertension	hypertension	NOUN
ajst-1502	69	36	.	.	PUNCT
ajst-1502	70	1	the	the	DET
ajst-1502	70	2	relationship	relationship	NOUN
ajst-1502	70	3	provides	provide	VERB
ajst-1502	70	4	new	new	ADJ
ajst-1502	70	5	ideas	idea	NOUN
ajst-1502	70	6	for	for	ADP
ajst-1502	70	7	the	the	DET
ajst-1502	70	8	prevention	prevention	NOUN
ajst-1502	70	9	and	and	CCONJ
ajst-1502	70	10	treatment	treatment	NOUN
ajst-1502	70	11	of	of	ADP
ajst-1502	70	12	hypertension	hypertension	NOUN
ajst-1502	70	13	.	.	PUNCT
ajst-1502	71	1	in	in	ADP
ajst-1502	71	2	the	the	DET
ajst-1502	71	3	study	study	NOUN
ajst-1502	71	4	,	,	PUNCT
ajst-1502	71	5	we	we	PRON
ajst-1502	71	6	found	find	VERB
ajst-1502	71	7	that	that	SCONJ
ajst-1502	71	8	there	there	PRON
ajst-1502	71	9	were	be	VERB
ajst-1502	71	10	three	three	NUM
ajst-1502	71	11	genotypes	genotype	NOUN
ajst-1502	71	12	of	of	ADP
ajst-1502	71	13	c	c	PROPN
ajst-1502	71	14	/	/	SYM
ajst-1502	71	15	c	c	NOUN
ajst-1502	71	16	,	,	PUNCT
ajst-1502	71	17	c	c	NOUN
ajst-1502	71	18	/	/	SYM
ajst-1502	71	19	t	t	PROPN
ajst-1502	71	20	and	and	CCONJ
ajst-1502	71	21	t	t	PROPN
ajst-1502	71	22	/	/	SYM
ajst-1502	71	23	t	t	PROPN
ajst-1502	71	24	in	in	ADP
ajst-1502	71	25	the	the	DET
ajst-1502	71	26	il-10	il-10	PRON
ajst-1502	71	27	-	-	PUNCT
ajst-1502	71	28	819	819	NUM
ajst-1502	71	29	locus	locus	NOUN
ajst-1502	71	30	in	in	ADP
ajst-1502	71	31	the	the	DET
ajst-1502	71	32	experimental	experimental	ADJ
ajst-1502	71	33	group	group	NOUN
ajst-1502	71	34	and	and	CCONJ
ajst-1502	71	35	the	the	DET
ajst-1502	71	36	control	control	NOUN
ajst-1502	71	37	group	group	NOUN
ajst-1502	71	38	,	,	PUNCT
ajst-1502	71	39	and	and	CCONJ
ajst-1502	71	40	g	g	NOUN
ajst-1502	71	41	/	/	SYM
ajst-1502	71	42	g	g	PROPN
ajst-1502	71	43	and	and	CCONJ
ajst-1502	71	44	g	g	PROPN
ajst-1502	71	45	were	be	AUX
ajst-1502	71	46	present	present	ADJ
ajst-1502	71	47	in	in	ADP
ajst-1502	71	48	the	the	DET
ajst-1502	71	49	il-10	il-10	PRON
ajst-1502	71	50	-	-	PUNCT
ajst-1502	71	51	1082	1082	NUM
ajst-1502	71	52	locus	locus	NOUN
ajst-1502	71	53	.	.	PUNCT
ajst-1502	72	1	there	there	PRON
ajst-1502	72	2	was	be	VERB
ajst-1502	72	3	no	no	DET
ajst-1502	72	4	significant	significant	ADJ
ajst-1502	72	5	difference	difference	NOUN
ajst-1502	72	6	in	in	ADP
ajst-1502	72	7	the	the	PRON
ajst-1502	72	8	/a	/a	PUNCT
ajst-1502	72	9	and	and	CCONJ
ajst-1502	72	10	a	a	DET
ajst-1502	72	11	/	/	SYM
ajst-1502	72	12	a	a	DET
ajst-1502	72	13	genotypes	genotype	NOUN
ajst-1502	72	14	between	between	ADP
ajst-1502	72	15	the	the	DET
ajst-1502	72	16	two	two	NUM
ajst-1502	72	17	groups	group	NOUN
ajst-1502	72	18	(	(	PUNCT
ajst-1502	72	19	p>0.05	p>0.05	PROPN
ajst-1502	72	20	)	)	PUNCT
ajst-1502	72	21	.	.	PUNCT
ajst-1502	73	1	logistic	logistic	ADJ
ajst-1502	73	2	regression	regression	NOUN
ajst-1502	73	3	analysis	analysis	NOUN
ajst-1502	73	4	showed	show	VERB
ajst-1502	73	5	that	that	SCONJ
ajst-1502	73	6	compared	compare	VERB
ajst-1502	73	7	with	with	ADP
ajst-1502	73	8	il10	il10	PROPN
ajst-1502	73	9	-	-	PUNCT
ajst-1502	73	10	819c	819c	VERB
ajst-1502	73	11	/	/	SYM
ajst-1502	73	12	c	c	NOUN
ajst-1502	73	13	genotype	genotype	NOUN
ajst-1502	73	14	,	,	PUNCT
ajst-1502	73	15	the	the	DET
ajst-1502	73	16	risk	risk	NOUN
ajst-1502	73	17	of	of	ADP
ajst-1502	73	18	hypertension	hypertension	NOUN
ajst-1502	73	19	in	in	ADP
ajst-1502	73	20	the	the	DET
ajst-1502	73	21	population	population	NOUN
ajst-1502	73	22	carrying	carry	VERB
ajst-1502	73	23	il-10	il-10	PRON
ajst-1502	73	24	-	-	PUNCT
ajst-1502	73	25	819c	819c	VERB
ajst-1502	73	26	/	/	SYM
ajst-1502	73	27	t	t	PROPN
ajst-1502	73	28	and	and	CCONJ
ajst-1502	73	29	t	t	PROPN
ajst-1502	73	30	/	/	SYM
ajst-1502	73	31	t	t	PROPN
ajst-1502	73	32	genotypes	genotype	NOUN
ajst-1502	73	33	was	be	AUX
ajst-1502	73	34	or＝1.19	or＝1.19	ADJ
ajst-1502	73	35	(	(	PUNCT
ajst-1502	73	36	95%ci＝0.71~1.05	95%ci＝0.71~1.05	NOUN
ajst-1502	73	37	)	)	PUNCT
ajst-1502	73	38	,	,	PUNCT
ajst-1502	73	39	χ２=0.73	χ２=0.73	ADJ
ajst-1502	73	40	,	,	PUNCT
ajst-1502	73	41	p>0.05	p>0.05	NOUN
ajst-1502	73	42	,	,	PUNCT
ajst-1502	73	43	or＝	or＝	PROPN
ajst-1502	73	44	1.05	1.05	NUM
ajst-1502	73	45	(	(	PUNCT
ajst-1502	73	46	95%ci＝1.01~1.10	95%ci＝1.01~1.10	NUM
ajst-1502	73	47	)	)	PUNCT
ajst-1502	73	48	,	,	PUNCT
ajst-1502	73	49	χ２=0.96,p>0.05	χ２=0.96,p>0.05	NOUN
ajst-1502	73	50	,	,	PUNCT
ajst-1502	73	51	the	the	DET
ajst-1502	73	52	difference	difference	NOUN
ajst-1502	73	53	was	be	AUX
ajst-1502	73	54	not	not	PART
ajst-1502	73	55	statistically	statistically	ADV
ajst-1502	73	56	significant	significant	ADJ
ajst-1502	73	57	(	(	PUNCT
ajst-1502	73	58	p>0.05	p>0.05	PROPN
ajst-1502	73	59	)	)	PUNCT
ajst-1502	73	60	.	.	PUNCT
ajst-1502	74	1	compared	compare	VERB
ajst-1502	74	2	with	with	ADP
ajst-1502	74	3	il10	il10	PROPN
ajst-1502	74	4	-	-	PUNCT
ajst-1502	74	5	1082a	1082a	NUM
ajst-1502	74	6	/	/	SYM
ajst-1502	74	7	a	a	PRON
ajst-1502	74	8	,	,	PUNCT
ajst-1502	74	9	the	the	DET
ajst-1502	74	10	risk	risk	NOUN
ajst-1502	74	11	of	of	ADP
ajst-1502	74	12	developing	develop	VERB
ajst-1502	74	13	hypertension	hypertension	NOUN
ajst-1502	74	14	in	in	ADP
ajst-1502	74	15	the	the	DET
ajst-1502	74	16	population	population	NOUN
ajst-1502	74	17	expressing	express	VERB
ajst-1502	74	18	il-10	il-10	NOUN
ajst-1502	74	19	-	-	SYM
ajst-1502	74	20	1082g	1082g	NUM
ajst-1502	74	21	/	/	SYM
ajst-1502	74	22	a	a	PRON
ajst-1502	74	23	and	and	CCONJ
ajst-1502	74	24	g	g	NOUN
ajst-1502	74	25	/	/	SYM
ajst-1502	74	26	g	g	NOUN
ajst-1502	74	27	genotypes	genotype	NOUN
ajst-1502	74	28	was	be	AUX
ajst-1502	74	29	or＝1.2	or＝1.2	ADJ
ajst-1502	74	30	(	(	PUNCT
ajst-1502	74	31	95%ci＝0.76~1.12	95%ci＝0.76~1.12	NUM
ajst-1502	74	32	)	)	PUNCT
ajst-1502	74	33	,	,	PUNCT
ajst-1502	74	34	χ２=0.704	χ２=0.704	NUM
ajst-1502	74	35	,	,	PUNCT
ajst-1502	74	36	p>0.737,or	p>0.737,or	VERB
ajst-1502	74	37	＝1.33	＝1.33	PROPN
ajst-1502	74	38	(	(	PUNCT
ajst-1502	74	39	95	95	NUM
ajst-1502	74	40	%	%	NOUN
ajst-1502	74	41	ci＝0.77~1.33	ci＝0.77~1.33	NOUN
ajst-1502	74	42	)	)	PUNCT
ajst-1502	74	43	,	,	PUNCT
ajst-1502	74	44	χ２=0.97,p>0.05	χ２=0.97,p>0.05	NOUN
ajst-1502	74	45	,	,	PUNCT
ajst-1502	74	46	the	the	DET
ajst-1502	74	47	difference	difference	NOUN
ajst-1502	74	48	was	be	AUX
ajst-1502	74	49	not	not	PART
ajst-1502	74	50	statistically	statistically	ADV
ajst-1502	74	51	significant	significant	ADJ
ajst-1502	74	52	(	(	PUNCT
ajst-1502	74	53	p>0.05	p>0.05	PROPN
ajst-1502	74	54	)	)	PUNCT
ajst-1502	74	55	.	.	PUNCT
ajst-1502	75	1	this	this	PRON
ajst-1502	75	2	further	far	ADV
ajst-1502	75	3	revealed	reveal	VERB
ajst-1502	75	4	that	that	SCONJ
ajst-1502	75	5	the	the	DET
ajst-1502	75	6	il-10	il-10	NOUN
ajst-1502	75	7	-	-	PUNCT
ajst-1502	75	8	819	819	NUM
ajst-1502	75	9	and	and	CCONJ
ajst-1502	75	10	-1082	-1082	NOUN
ajst-1502	75	11	genotype	genotype	NOUN
ajst-1502	75	12	mutations	mutation	NOUN
ajst-1502	75	13	in	in	ADP
ajst-1502	75	14	the	the	DET
ajst-1502	75	15	han	han	PROPN
ajst-1502	75	16	population	population	NOUN
ajst-1502	75	17	of	of	ADP
ajst-1502	75	18	jianghan	jianghan	PROPN
ajst-1502	75	19	plain	plain	PROPN
ajst-1502	75	20	were	be	AUX
ajst-1502	75	21	not	not	PART
ajst-1502	75	22	associated	associate	VERB
ajst-1502	75	23	with	with	ADP
ajst-1502	75	24	the	the	DET
ajst-1502	75	25	onset	onset	NOUN
ajst-1502	75	26	of	of	ADP
ajst-1502	75	27	hypertension	hypertension	NOUN
ajst-1502	75	28	.	.	PUNCT
ajst-1502	76	1	the	the	DET
ajst-1502	76	2	occurrence	occurrence	NOUN
ajst-1502	76	3	of	of	ADP
ajst-1502	76	4	hypertension	hypertension	NOUN
ajst-1502	76	5	is	be	AUX
ajst-1502	76	6	the	the	DET
ajst-1502	76	7	result	result	NOUN
ajst-1502	76	8	of	of	ADP
ajst-1502	76	9	the	the	DET
ajst-1502	76	10	interaction	interaction	NOUN
ajst-1502	76	11	of	of	ADP
ajst-1502	76	12	multiple	multiple	ADJ
ajst-1502	76	13	environmental	environmental	ADJ
ajst-1502	76	14	factors	factor	NOUN
ajst-1502	76	15	,	,	PUNCT
ajst-1502	76	16	multiple	multiple	ADJ
ajst-1502	76	17	pathological	pathological	ADJ
ajst-1502	76	18	processes	process	NOUN
ajst-1502	76	19	,	,	PUNCT
ajst-1502	76	20	and	and	CCONJ
ajst-1502	76	21	multiple	multiple	ADJ
ajst-1502	76	22	genetic	genetic	ADJ
ajst-1502	76	23	factors	factor	NOUN
ajst-1502	76	24	.	.	PUNCT
ajst-1502	77	1	relative	relative	ADJ
ajst-1502	77	2	to	to	ADP
ajst-1502	77	3	the	the	DET
ajst-1502	77	4	susceptibility	susceptibility	NOUN
ajst-1502	77	5	factors	factor	NOUN
ajst-1502	77	6	of	of	ADP
ajst-1502	77	7	hypertension	hypertension	NOUN
ajst-1502	77	8	,	,	PUNCT
ajst-1502	77	9	the	the	DET
ajst-1502	77	10	presence	presence	NOUN
ajst-1502	77	11	of	of	ADP
ajst-1502	77	12	this	this	DET
ajst-1502	77	13	polymorphism	polymorphism	NOUN
ajst-1502	77	14	site	site	NOUN
ajst-1502	77	15	interacts	interact	VERB
ajst-1502	77	16	with	with	ADP
ajst-1502	77	17	other	other	ADJ
ajst-1502	77	18	risk	risk	NOUN
ajst-1502	77	19	factors	factor	NOUN
ajst-1502	77	20	and	and	CCONJ
ajst-1502	77	21	plays	play	VERB
ajst-1502	77	22	a	a	DET
ajst-1502	77	23	role	role	NOUN
ajst-1502	77	24	in	in	ADP
ajst-1502	77	25	the	the	DET
ajst-1502	77	26	occurrence	occurrence	NOUN
ajst-1502	77	27	and	and	CCONJ
ajst-1502	77	28	development	development	NOUN
ajst-1502	77	29	of	of	ADP
ajst-1502	77	30	the	the	DET
ajst-1502	77	31	disease	disease	NOUN
ajst-1502	77	32	.	.	PUNCT
ajst-1502	78	1	the	the	DET
ajst-1502	78	2	single	single	ADJ
ajst-1502	78	3	factor	factor	NOUN
ajst-1502	78	4	occurs	occur	VERB
ajst-1502	78	5	in	in	ADP
ajst-1502	78	6	the	the	DET
ajst-1502	78	7	han	han	PROPN
ajst-1502	78	8	nationality	nationality	NOUN
ajst-1502	78	9	patients	patient	NOUN
ajst-1502	78	10	in	in	ADP
ajst-1502	78	11	jianghan	jianghan	PROPN
ajst-1502	78	12	plain	plain	PROPN
ajst-1502	78	13	.	.	PUNCT
ajst-1502	79	1	it	it	PRON
ajst-1502	79	2	does	do	AUX
ajst-1502	79	3	not	not	PART
ajst-1502	79	4	work	work	VERB
ajst-1502	79	5	in	in	ADP
ajst-1502	79	6	isolation	isolation	NOUN
ajst-1502	79	7	with	with	ADP
ajst-1502	79	8	development	development	NOUN
ajst-1502	79	9	.	.	PUNCT
ajst-1502	80	1	due	due	ADP
ajst-1502	80	2	to	to	ADP
ajst-1502	80	3	the	the	DET
ajst-1502	80	4	short	short	ADJ
ajst-1502	80	5	time	time	NOUN
ajst-1502	80	6	of	of	ADP
ajst-1502	80	7	this	this	DET
ajst-1502	80	8	study	study	NOUN
ajst-1502	80	9	,	,	PUNCT
ajst-1502	80	10	the	the	DET
ajst-1502	80	11	sample	sample	NOUN
ajst-1502	80	12	size	size	NOUN
ajst-1502	80	13	collected	collect	VERB
ajst-1502	80	14	87	87	NUM
ajst-1502	80	15	is	be	AUX
ajst-1502	80	16	small	small	ADJ
ajst-1502	80	17	,	,	PUNCT
ajst-1502	80	18	and	and	CCONJ
ajst-1502	80	19	the	the	DET
ajst-1502	80	20	genetic	genetic	ADJ
ajst-1502	80	21	polymorphism	polymorphism	NOUN
ajst-1502	80	22	is	be	AUX
ajst-1502	80	23	greatly	greatly	ADV
ajst-1502	80	24	affected	affect	VERB
ajst-1502	80	25	by	by	ADP
ajst-1502	80	26	the	the	DET
ajst-1502	80	27	environment	environment	NOUN
ajst-1502	80	28	and	and	CCONJ
ajst-1502	80	29	ethnicity	ethnicity	NOUN
ajst-1502	80	30	.	.	PUNCT
ajst-1502	81	1	therefore	therefore	ADV
ajst-1502	81	2	,	,	PUNCT
ajst-1502	81	3	the	the	DET
ajst-1502	81	4	refinement	refinement	NOUN
ajst-1502	81	5	of	of	ADP
ajst-1502	81	6	the	the	DET
ajst-1502	81	7	population	population	NOUN
ajst-1502	81	8	classification	classification	NOUN
ajst-1502	81	9	will	will	AUX
ajst-1502	81	10	be	be	AUX
ajst-1502	81	11	further	far	ADV
ajst-1502	81	12	studied	study	VERB
ajst-1502	81	13	.	.	PUNCT
ajst-1502	82	1	references	reference	NOUN
ajst-1502	82	2	[	[	X
ajst-1502	82	3	1	1	NUM
ajst-1502	82	4	]	]	PUNCT
ajst-1502	82	5	yufen	yufen	PROPN
ajst-1502	82	6	gao	gao	PROPN
ajst-1502	82	7	,	,	PUNCT
ajst-1502	82	8	jingkai	jingkai	PROPN
ajst-1502	82	9	chan	chan	PROPN
ajst-1502	82	10	and	and	CCONJ
ajst-1502	82	11	gangjun	gangjun	VERB
ajst-1502	82	12	chung.changes	chung.change	NOUN
ajst-1502	82	13	of	of	ADP
ajst-1502	82	14	microalbuminuria	microalbuminuria	ADJ
ajst-1502	82	15	and	and	CCONJ
ajst-1502	82	16	inflammatory	inflammatory	ADJ
ajst-1502	82	17	factors	factor	NOUN
ajst-1502	82	18	in	in	ADP
ajst-1502	82	19	prehypertensive	prehypertensive	NOUN
ajst-1502	82	20	population[j].chongqing	population[j].chongqe	VERB
ajst-1502	82	21	medical	medical	ADJ
ajst-1502	82	22	journal,2014,43(21):27882791	journal,2014,43(21):27882791	NOUN
ajst-1502	82	23	.	.	PUNCT
ajst-1502	83	1	[	[	X
ajst-1502	83	2	2	2	X
ajst-1502	83	3	]	]	X
ajst-1502	83	4	anand	anand	PROPN
ajst-1502	83	5	r	r	PROPN
ajst-1502	83	6	,	,	PUNCT
ajst-1502	83	7	nair	nair	NOUN
ajst-1502	83	8	,	,	PUNCT
ajst-1502	83	9	philip	philip	PROPN
ajst-1502	83	10	j.angiotensin	j.angiotensin	PROPN
ajst-1502	83	11	ii	ii	PROPN
ajst-1502	83	12	-	-	PUNCT
ajst-1502	83	13	induced	induce	VERB
ajst-1502	83	14	hypertensive	hypertensive	ADJ
ajst-1502	83	15	renal	renal	ADJ
ajst-1502	83	16	inflammation	inflammation	NOUN
ajst-1502	83	17	is	be	AUX
ajst-1502	83	18	mediated	mediate	VERB
ajst-1502	83	19	through	through	ADP
ajst-1502	83	20	hmgb1	hmgb1	PROPN
ajst-1502	83	21	-	-	PUNCT
ajst-1502	83	22	tlr4	tlr4	NOUN
ajst-1502	83	23	signaling	signal	VERB
ajst-1502	83	24	in	in	ADP
ajst-1502	83	25	rat	rat	NOUN
ajst-1502	83	26	tubulo	tubulo	ADJ
ajst-1502	83	27	-	-	PUNCT
ajst-1502	83	28	epithelial	epithelial	ADJ
ajst-1502	83	29	cells[j].experimental	cells[j].experimental	ADJ
ajst-1502	83	30	cell	cell	NOUN
ajst-1502	83	31	research,2015,335(2	research,2015,335(2	NOUN
ajst-1502	83	32	):	):	PUNCT
ajst-1502	83	33	238	238	NUM
ajst-1502	83	34	-	-	SYM
ajst-1502	83	35	247	247	NUM
ajst-1502	83	36	.	.	PUNCT
ajst-1502	84	1	[	[	X
ajst-1502	84	2	3	3	X
ajst-1502	84	3	]	]	X
ajst-1502	84	4	zhaopeng	zhaopeng	X
ajst-1502	84	5	chou	chou	NOUN
ajst-1502	84	6	,	,	PUNCT
ajst-1502	84	7	zujian	zujian	PROPN
ajst-1502	84	8	hui	hui	PROPN
ajst-1502	84	9	and	and	CCONJ
ajst-1502	84	10	xiaohua	xiaohua	PROPN
ajst-1502	84	11	day.relationship	day.relationship	NOUN
ajst-1502	84	12	between	between	ADP
ajst-1502	84	13	essential	essential	ADJ
ajst-1502	84	14	hypertension	hypertension	NOUN
ajst-1502	84	15	and	and	CCONJ
ajst-1502	84	16	inflammatory	inflammatory	ADJ
ajst-1502	84	17	factors	factor	NOUN
ajst-1502	84	18	and	and	CCONJ
ajst-1502	84	19	intervention	intervention	NOUN
ajst-1502	84	20	of	of	ADP
ajst-1502	84	21	traditional	traditional	ADJ
ajst-1502	84	22	chinese	chinese	ADJ
ajst-1502	84	23	medicine[j].journal	medicine[j].journal	NOUN
ajst-1502	84	24	of	of	ADP
ajst-1502	84	25	traditional	traditional	ADJ
ajst-1502	84	26	chinese	chinese	ADJ
ajst-1502	84	27	medicine	medicine	NOUN
ajst-1502	84	28	and	and	CCONJ
ajst-1502	84	29	clinical	clinical	ADJ
ajst-1502	84	30	medicine	medicine	NOUN
ajst-1502	84	31	,	,	PUNCT
ajst-1502	84	32	2015	2015	NUM
ajst-1502	84	33	,	,	PUNCT
ajst-1502	84	34	27(3	27(3	NUM
ajst-1502	84	35	):	):	PUNCT
ajst-1502	84	36	307	307	NUM
ajst-1502	84	37	-	-	SYM
ajst-1502	84	38	310	310	NUM
ajst-1502	84	39	.	.	PUNCT
ajst-1502	85	1	[	[	X
ajst-1502	85	2	4	4	X
ajst-1502	85	3	]	]	X
ajst-1502	85	4	hua	hua	PROPN
ajst-1502	85	5	chang	chang	PROPN
ajst-1502	85	6	,	,	PUNCT
ajst-1502	85	7	lixiang	lixiang	PROPN
ajst-1502	85	8	liu	liu	PROPN
ajst-1502	85	9	and	and	CCONJ
ajst-1502	85	10	zhi	zhi	PROPN
ajst-1502	85	11	liu	liu	PROPN
ajst-1502	85	12	.	.	PUNCT
ajst-1502	85	13	changes	change	NOUN
ajst-1502	85	14	and	and	CCONJ
ajst-1502	85	15	significance	significance	NOUN
ajst-1502	85	16	of	of	ADP
ajst-1502	85	17	serum	serum	NOUN
ajst-1502	85	18	il-6	il-6	NOUN
ajst-1502	85	19	,	,	PUNCT
ajst-1502	85	20	il-10	il-10	PRON
ajst-1502	85	21	and	and	CCONJ
ajst-1502	85	22	tnf	tnf	PROPN
ajst-1502	85	23	-	-	PUNCT
ajst-1502	85	24	α	α	PROPN
ajst-1502	85	25	levels	level	NOUN
ajst-1502	85	26	in	in	ADP
ajst-1502	85	27	patients	patient	NOUN
ajst-1502	85	28	with	with	ADP
ajst-1502	85	29	diabetes	diabetes	NOUN
ajst-1502	85	30	mellitus	mellitus	NOUN
ajst-1502	85	31	complicated	complicate	VERB
ajst-1502	85	32	with	with	ADP
ajst-1502	85	33	hypertension[j].shandong	hypertension[j].shandong	PROPN
ajst-1502	85	34	medical	medical	ADJ
ajst-1502	85	35	journal	journal	NOUN
ajst-1502	85	36	,	,	PUNCT
ajst-1502	85	37	2015,55(19):79	2015,55(19):79	NOUN
ajst-1502	85	38	-	-	SYM
ajst-1502	85	39	80	80	NUM
ajst-1502	85	40	.	.	PUNCT
ajst-1502	86	1	[	[	X
ajst-1502	86	2	5	5	NUM
ajst-1502	86	3	]	]	PUNCT
ajst-1502	86	4	china	china	PROPN
ajst-1502	86	5	hypertension	hypertension	PROPN
ajst-1502	86	6	prevention	prevention	PROPN
ajst-1502	86	7	and	and	CCONJ
ajst-1502	86	8	treatment	treatment	NOUN
ajst-1502	86	9	guidelines	guideline	NOUN
ajst-1502	86	10	revision	revision	NOUN
ajst-1502	86	11	committee	committee	NOUN
ajst-1502	86	12	.	.	PUNCT
ajst-1502	87	1	china	china	PROPN
ajst-1502	87	2	guidelines	guideline	VERB
ajst-1502	87	3	for	for	ADP
ajst-1502	87	4	prevention	prevention	NOUN
ajst-1502	87	5	and	and	CCONJ
ajst-1502	87	6	treatment	treatment	NOUN
ajst-1502	87	7	of	of	ADP
ajst-1502	87	8	hypertension	hypertension	NOUN
ajst-1502	87	9	2010[j].chinese	2010[j].chinese	NUM
ajst-1502	87	10	journal	journal	NOUN
ajst-1502	87	11	of	of	ADP
ajst-1502	87	12	hypertension	hypertension	NOUN
ajst-1502	87	13	,	,	PUNCT
ajst-1502	87	14	2011	2011	NUM
ajst-1502	87	15	;	;	PUNCT
ajst-1502	87	16	19(8	19(8	NUM
ajst-1502	87	17	):	):	PUNCT
ajst-1502	87	18	701	701	NUM
ajst-1502	87	19	-	-	SYM
ajst-1502	87	20	743	743	NUM
ajst-1502	87	21	.	.	PUNCT
ajst-1502	88	1	[	[	X
ajst-1502	88	2	6	6	NUM
ajst-1502	88	3	]	]	PUNCT
ajst-1502	88	4	ruicheng	ruicheng	PROPN
ajst-1502	88	5	hu	hu	PROPN
ajst-1502	88	6	,	,	PUNCT
ajst-1502	88	7	yongjian	yongjian	PROPN
ajst-1502	88	8	xu	xu	PROPN
ajst-1502	88	9	,	,	PUNCT
ajst-1502	88	10	zhenxiang	zhenxiang	PROPN
ajst-1502	88	11	chang	chang	PROPN
ajst-1502	88	12	and	and	CCONJ
ajst-1502	88	13	et	et	PROPN
ajst-1502	88	14	.	.	PUNCT
ajst-1502	88	15	relationship	relationship	NOUN
ajst-1502	88	16	between	between	ADP
ajst-1502	88	17	interleukin-10	interleukin-10	PROPN
ajst-1502	88	18	gene	gene	NOUN
ajst-1502	88	19	promoter	promoter	NOUN
ajst-1502	88	20	polymorphism	polymorphism	NOUN
ajst-1502	88	21	and	and	CCONJ
ajst-1502	88	22	susceptibility	susceptibility	NOUN
ajst-1502	88	23	to	to	PART
ajst-1502	88	24	chronic	chronic	VERB
ajst-1502	88	25	obstructive	obstructive	ADJ
ajst-1502	88	26	pulmonary	pulmonary	ADJ
ajst-1502	88	27	disease	disease	NOUN
ajst-1502	89	1	[	[	X
ajst-1502	89	2	j	j	X
ajst-1502	89	3	]	]	X
ajst-1502	89	4	.	.	PUNCT
ajst-1502	90	1	chinese	chinese	ADJ
ajst-1502	90	2	journal	journal	PROPN
ajst-1502	90	3	of	of	ADP
ajst-1502	90	4	medical	medical	ADJ
ajst-1502	90	5	genetics	genetic	NOUN
ajst-1502	90	6	,	,	PUNCT
ajst-1502	90	7	2003	2003	NUM
ajst-1502	90	8	;	;	PUNCT
ajst-1502	90	9	20:503	20:503	NUM
ajst-1502	90	10	-	-	SYM
ajst-1502	90	11	507	507	NUM
ajst-1502	90	12	.	.	PUNCT
ajst-1502	91	1	[	[	X
ajst-1502	91	2	7	7	NUM
ajst-1502	91	3	]	]	SYM
ajst-1502	91	4	osborn	osborn	PROPN
ajst-1502	91	5	o	o	PROPN
ajst-1502	91	6	,	,	PUNCT
ajst-1502	91	7	olefsky	olefsky	PROPN
ajst-1502	91	8	jm	jm	PROPN
ajst-1502	91	9	.	.	PUNCT
ajst-1502	92	1	the	the	DET
ajst-1502	92	2	cellular	cellular	ADJ
ajst-1502	92	3	and	and	CCONJ
ajst-1502	92	4	signaling	signal	VERB
ajst-1502	92	5	networks	network	NOUN
ajst-1502	92	6	linking	link	VERB
ajst-1502	92	7	the	the	DET
ajst-1502	92	8	immune	immune	ADJ
ajst-1502	92	9	system	system	NOUN
ajst-1502	92	10	and	and	CCONJ
ajst-1502	92	11	metabolism	metabolism	NOUN
ajst-1502	92	12	in	in	ADP
ajst-1502	92	13	disease	disease	NOUN
ajst-1502	92	14	[	[	X
ajst-1502	92	15	j	j	X
ajst-1502	92	16	]	]	X
ajst-1502	92	17	.	.	PUNCT
ajst-1502	93	1	nature	nature	NOUN
ajst-1502	93	2	medicine	medicine	NOUN
ajst-1502	93	3	,	,	PUNCT
ajst-1502	93	4	2012	2012	NUM
ajst-1502	93	5	,	,	PUNCT
ajst-1502	93	6	18(3	18(3	NUM
ajst-1502	93	7	):	):	PUNCT
ajst-1502	93	8	363–374	363–374	NUM
ajst-1502	93	9	.	.	PUNCT
ajst-1502	94	1	[	[	X
ajst-1502	94	2	8	8	NUM
ajst-1502	94	3	]	]	PUNCT
ajst-1502	94	4	zhaohui	zhaohui	PROPN
ajst-1502	94	5	chiang	chiang	PROPN
ajst-1502	94	6	,	,	PUNCT
ajst-1502	94	7	jianjun	jianjun	PROPN
ajst-1502	94	8	wong	wong	PROPN
ajst-1502	94	9	and	and	CCONJ
ajst-1502	94	10	wenmin	wenmin	PROPN
ajst-1502	94	11	chan	chan	PROPN
ajst-1502	94	12	.	.	PUNCT
ajst-1502	95	1	determination	determination	NOUN
ajst-1502	95	2	and	and	CCONJ
ajst-1502	95	3	significance	significance	NOUN
ajst-1502	95	4	of	of	ADP
ajst-1502	95	5	tnf	tnf	PROPN
ajst-1502	95	6	-	-	PUNCT
ajst-1502	95	7	α	α	PROPN
ajst-1502	95	8	and	and	CCONJ
ajst-1502	95	9	nf	nf	NOUN
ajst-1502	95	10	-	-	PUNCT
ajst-1502	95	11	κb	κb	NOUN
ajst-1502	95	12	in	in	ADP
ajst-1502	95	13	serum	serum	NOUN
ajst-1502	95	14	of	of	ADP
ajst-1502	95	15	patients	patient	NOUN
ajst-1502	95	16	with	with	ADP
ajst-1502	95	17	essential	essential	ADJ
ajst-1502	95	18	hypertension[j].medical	hypertension[j].medical	ADJ
ajst-1502	95	19	clinical	clinical	ADJ
ajst-1502	95	20	research	research	NOUN
ajst-1502	95	21	,	,	PUNCT
ajst-1502	95	22	2014,31(3):527	2014,31(3):527	NUM
ajst-1502	95	23	-	-	SYM
ajst-1502	95	24	530	530	NUM
ajst-1502	95	25	.	.	PUNCT